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Upcoming Events
February 14, Friday
Alumni reception at the meeting of the American Academy
of Orthopaedic Surgeons. San Francisco. CA
Receptions in Califor-nia
Februmy 18 Los Angeles
F('bnlar)' 19 San Diego
February 20 San Francisco
fcbmary 22-28 Continuing Medical Education
Jefferson Ane sthesia Conference for
Cro ss Count ry and Downhill Skiers
Lone Mountain Ranch. Big Sky. Montana
For information call toll-free 1-888-/EFF-CME
Mal"Ch 1-2 Continuing Medical Education
Imaging of the Shoulder and Elbow with
Emphasis on Medical Clinical Relevance
Jefferson Medical College. Philadelphia
For information call toll -free 1-888-JEFF-CME
Mm'ch 5-8 Continuing Medical Education
24th Annual Course in Electrodiagno sis
and Clin ical Neurophy siology
Bluernle Life Sciences Building. Jefferson Medical College
For information call toll -free 1-888-JEFF-CME
MOl-d. 14, Friday
Parents Day for the Sophomore Class and their families
MOl-d. 23 , Sunday
Alumni reception at the meeting of the American College
of Phy sicians. Philadelphia. PA
Mard. 23, Sund ay
Alumni reception at the meeting of the American Academy
of D ermatology. San Francisco. CA
Mard. 31-April 4 Continuing Medical Education
Bermuda Shorts for Clinical Anesthesiologists
Sonesta Beach Resort. Bermuda
For information call toll-free 1-888-JEFF-CME
April 4, Frid ay Continuing Medical Education
De rmatology in General Medicine
jefferson Medical College. Philadelphia. PA
For informati on call toll -free 1-888-)EFF-CME
A,,,il 13-14 Continuing Medical Education
Jefferson Foot and Ankle Advanced Imaging Symposium
Jefferson Medical College. Philadelphia
For information call toll-free 1-888-IEFF-CME
April19-20 Continuing Medical Education
The Fourth Annual Cardiovascular Radiology Review Weekend
lefferson Medical College. Philadelphia
For information call toll -free 1-888-JEFF-CME
AIJril 24, Thursday
Alumni Annual Business Meeting
Apr-j/ 27 , Sunday
Alumni reception at the meeting of the American College
of Obstetricians and Gynecologists. Las Vegas. NV
May 9-10 Conti nuing Medica l Education
Jefferson Cytopathol ogy Review Course
Jefferson Medical College. Philadelphia
For information call toll -free 1-888-JEFF-CM E
May 18, Sunday
Alumni reception at the meeting of the Am erican Psy chiatric
A ssociation . San Diego. CA
May 21 , Wednesday
Reception and Dinner. W ilkes-Barr e. PA
May 31 , Saturday Con tinuing Medi cal Education
Cardiology: Balancing the Art and Science
Jefferson Medical College. Philadelphia
For information call toll -free 1-888-JEFF-CME
Reunion Wceltend
june 6 Alumni Banquet
jllnc 7 Clinic Presentations; D ean's Luncheon: Reunion Parties
junc 8 Farewell Brun ch
jllnc 13-21 Continuing Medical Education
Barge Trip in Burgundy regi on of France-see page II
[une 22-27 Continuing Medi cal Education
Eastern Shore Medical Symposium . Rehoboth Beach. Delaware
For information call toll -free 1-888-JEFF-CME
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This issue's cover features computer-generated images of
a potential CD4 -based drug developed at leff (see page 4) .
Rational drug design is providing the university wi th fur ther
opportunities in technology transfer (see page 7) and
clinical trials (see page 9).
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Ziwei Huang. Ph.D .
directs a team of
scientis ts who use
state-of- the-art
technology to
design new drug s.
like the one
shown on the cover.
Rational Drug Design
Translating Basic Research into New Medicines
n th e front and back covers of thi s issu e, an organic
inhibitor (the orange shape) design ed by Dr. Ziwei Huang's
lab or atory a t Jefferson is shown to bind to a sur face po ck et of
th e CD4 prot ein and thus block CD4-me d ia ted T cell responses
inv olved in tran splant rejection and a number of autoimmune
diseases . Using a co mpu te r , Dr. Hu an g and his coll eagu es hav e
found thi s orga nic drug lead which is so suc cess fu lly tailored to
th e nooks and cran nies of th e CD4 protein sur face that it binds
th e CD4 target with high affinity and tremendous spec ificity.
Th e discovery of thi s and other potential new drug molecules
using co m pu te r-base d technology is bein g reponed in
th e Proceedings of thc National Acadcmy of Sciences USA
(janua ry 7, 1997 issu e) and is on e of th e lat est examples of
rati onal drug design at Jeff. "This is truly groundbreak ing
wo rk, " says Carlo M. Croce, M.D., Director of Jefferson's
Kimmel Cance r Ce nte r and Kimmel Cance r Institute. "Many
othe r protein s discovered her e at th e center can be looked at
in thi s way to design new drugs for cance r and othe r human
diseases ."
III /Ilis m1ide, we take CI dose looll CI/ the currc ur s rnrus of
j effa soll 's ra/iollal e/nlg e/esigll research , and the [utu re
promise i/ holds [or I-eCl/izillg die IIl1ivasi/y 's visi oll ill
/rallslatillg basi c sc tent ijic e/iscovelY ill/o new medi cin es for
die comillg ceunny,
Rati on al drug design (a lso known as structure-base d drug
design ) is an eme rging approac h that is revolutionizing the
practi ce of drug discovery. Tradition ally, a typi cal drug
development process takes mor e th an 10 yea rs and cos ts about
$ 100 million. Facin g tod ay's rapid cha nges in th e healt h care
environment, we can no lon ger afford suc h lengthy and
ex pens ive ways of finding th erapeutic age n ts to co mbat human
diseases . Rational drug design solves th ese problem s through
th e use of innovative co mpu te r technology co mbined with
many other di sciplines to spee d th e development process.
It begins with th e id entificati on of a molecul ar target such as a
protein by genetic and molecul ar biol ogical techniques , and the
structural stu dy of th e target by high -resolution crysta llography
and NMR spectrosc opy. Th e struc tural inform at ion abou t the
target is exploited by th e co mputer to design pot ential drug
mo lecules that regu late th e spec ific fun cti on of th e target.
Th e designed molecul es are th en sy nt hesized and modified
using peptide and organic che mistry techniques , tested for
biolo gical efficacy in various in vit ro and in vivo assay systems,
and finall y th e mo st promising lead is ge ne ra ted for clinical
trials in humans.
"Rational drug design has taken roo t at J efferson and received a
trem endous boost with th e arrival of Dr. Ziwei Huang from the
Universit y of Californ ia, San Fran cisco , in early 1995," says
Rob ert L. Cornis, M.D., Clin ical Director of th e Kim mel Cancer
Cen ter. Th e Rational Dru g Design Program was established wit h
th e vision of Dr. Ca rlo Croce and th e strong support and
resources provid ed by th e medi cal co llege an d th e university.
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After being designed on the computer . molecules are synthes ized and modi fi ed at the
Peptide Synthesi s Facility. located in the Bluernle Life Sciences BUilding and directed by Dr.
Huang. These potential peptide-based drugs are then put into preclinical studies.
J
cell. CD4 co ntac ts ano the r ant igen- pres enting protein called
maj or hist ocompatibility co mplex (MHC) class II duri ng th e
early s tage of th e T cell res po nse to an antigen . Because of th is,
CD4 pla ys a critica l rol e in regul ating th e immune syste m
which, if it goes awry , co u ld lead to pathological co nse que nces,
suc h as orga n tran spl ant rejecti on and autoi mm une diseases.
To contro l th e undesired immune respo nse in th ese d iseases ,
th erap eutic stra teg ies such as an anti -CD4 anti bo dy have
been developed . However , th e clini cal value of th ese
antibod y-based th erapies is limited du e to th eir immun ogeni city
when used in human s. To overco me thi s probl em, Dr. Huan g's
grou p resorted to a ra tiona l drug design approach to gene ra te
novel , small molecul ar CD4 inhibi tors . In co ntra st to an
antibod y, sma ll mole cules (s uc h as peptides or organic
co mpo unds) are not immunogen ic and th erefore can be used
for lon g per iod s o f tim e.
Using co mpu te rs , Dr. Hu an g's team looked at th e three-
dimensional shape of th e CD4 prot ein
and design ed small pep tides that cou ld
block CD4-me dia ted immune fun ction .
Th ese compu ter design and peptide
synthes is stud ies have led to th e
discovery of a small cyclic hepiapepude
which has been shown by the co llabo-
ra ting immunology lab oratory of Dr.
Rob ert Korngold a t Jefferson to be highl y
effective in anima l mod els for human
multiple sclerosis, orga n tran splant
rejecti on , and graft versus host disease
(GVHD) following bon e marro w
tran splantat ion .
In add ition to th e design of peptide drugs ,
th e co mputer is also used to selec t
pot ential orga nic CD4 inh ibitors from
large pools of exis ting co mpounds. Using
The Organic Synthesis Facility. recently establi shed within Dr. Huang 's laboratory. provides
an essenti al tool for produ cing a future generation of organic drug s. According to Dr.
Huang, the initial peptide drugs will eventually be replaced by more cost -effective and
orally available organic molecules .
Cur rently Dr. Hu an g's lab has a network of state-o f-the -art
co mpute rs including a four-processor mini-supercomputer. Th e
Peptide Synt hesis Facility direct ed by Dr. Huang is equ ipped
with four full y auto ma ted synt hesize rs th at can produce high -
qu alit y, biologically ac tive peptidcs as pot ential drugs for both
sma ll-sca le, in vitro assays and large-scal e, preclinical animal
stud ies. These resear ch in fras tructu res , together with othe r
ac tivities and program s in technology transfer and clinical trials
(see th e followin g two art icles , pages seve n and nine); ar e
int egral to Jefferson 's mission to co mbine stro ng basic research
with cli nica l exce llence to devel op a new ge ne ra tion of human
th erapi es .
The recent development of CD4- based drugs by Dr. Hu an g's
team se rves to highlight th e ge ne ral strategy of rational drug
design . CD4 is a glyco pro te in ex pressed on th e sur face of a T
The pr ojects' recent success is due to many
factors , ex plains Dr. Hu an g. Th e ge neti-
cis ts and molecul ar biologist s at th e
Kimmel Cancer Institute have discover ed
man y genes and th eir protein products
implicat ed in va rious patholo gical
cond itions, thus providing a bewildering
array of potential targets for drug design
stud ies. The es tablishment of th e X-ray
crys tallographic and high -field NMR
spectroscopic facilities at th e institute has
pro vided important tool s to obtain
struc tural information necessary for
initiating th e design o f a drug. Finally, th e com puter mod eling
and peptide synt hes is facilities have been esse nt ial.
Th e development of th e Medi cal Scie nce
Division at th e Kimmel Ca nce r Cen te r,
under th e direct ion of Dr. Co m is, has
p rovid ed th e environme nt critical for thi s
typ e of resear ch .
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sophisticated modelin g and graphics software, Dr. Huang and
his colleagues have identifi ed promising organi c inhibitors of
CD4 function. Compared to the CD4 pept ide drug, these
second-genera tion orga nic drugs possess several advantages:
their non-peptidic structures are less susce ptible to enzyma tic
degradation and thus are more stable; they could be taken
throu gh the oral route which is most desirable in term s of
patience compliance; and they are easily synt hes ized usin g
inexpensive materials, which significantly lowers the cost of the
therapeutic treatm en t.
The computer screening approach, as demonstrated in the
discovery of organic CD4 inhibitors , is a powerful tool in the
search for perfect drugs. In the past , many drugs were found
from a traditional process of random screening of 100,000 to
500,000 compounds. In con tras t to this laborious and expensive
rand om testing, the compu ter-based strategy as used in the CD4
study took less than a month to complete the scree ning of
approximately 150,000 compounds , and cos t very littl e since
the testing was do ne on the compute r instead of test tub es and
animals. "The orga nic drugs designed by the compute r sho uld
be far bett er than the ant ibodies, and these studies will open
new avenues for the development of effective medicin es," says
Hilary Koprowski, M.D., Director ofJefferson's Center for
euroviro logy.
"Rational drug desig n is a team effort , and the CD4 pr oject is a
good example," poin ts out Dr. Huang. The CD4 peptide and
organic inhibitor studies have involved the computer modelers
and dt ellli sts of Dr. Huang's lab including Song Li , Taka shi
Satoh, Ji min Gao , Xiaobing Han , Dani el Butcher , Zhaowen Luo ,
Simei Shan, Zhixian Lu, and Zhe ngdo ng Wu ; the illllllllllologists
of Dr. Korngo ld's lab includ ing Thea M. Friedma n, Andrea E.
Edling, Ute Koch , Swat i Cho ksi, Robert Tow nse nd, Joseph c.
Marini, Ryszard Wia derkiewicz, and Anna Wiaderki ewicz: and
the NMR spect roscopists of Dr. Markus W. Germann's lab
including James M. Aramini. According to Dr. Huang, this
multidisciplin ary collaboration and close teamwork have been
essential to the progress made in th e CD4 project.
C linical Tr ials Will Begin Soon
Through close collabo ration, Dr. Huang, Dr. Korngold , and
clinical colleagues from the Translational Research and Bon e
Marrow Transplant Programs at the Kimmel Cance r Center
have progressed to the point where a clinica l trial is imminent.
The remarkable aspect of the peptides is that there is no toxicity
associa ted with their use in anima ls. Plus there is clear-cut
synergy with existing medicin es used for GVHD in humans
such as cyclospo rin . GVHD is the principa l risk factor affecting
the surv ival of cancer patients undergoin g bone marrow
transplant at ion.
Dur ing 1997 the research ers will evalua te both the side effects
and activity of the CD4 peptide in patien ts who are at high risk
for severe GVHD after bone marrow tran splantation. Th ese
studies will be under the dir ection of Neal Flomenberg '76,
Director of the Bon e Marrow Transplant Program . Other clini cal
studies of the peptide will be conduc ted in patients with
multiple sclerosis.
In addi tion to their intrins ic importance, these initial trials will
lay the groundwo rk for employing the new organic molecul es
discovered from the computer scree ning. "We are very excited
abou t the clinical pot ential of these novel CD4 drugs ," says Dr.
Comis. "They will point out the future direction of our transla-
tional resea rch."
Th e CD4-based drugs, if they successfu lly pass human clini cal
trials and reach the market , will find many clinical applications
for autoimmune diseases suc h as multiple sclerosis and
rheumatoid arthritis and bon e mar row and orga n transplan-
tation . Th eir commercial potenti al will be enormous as there is
an estimated billion -dollar market for suc h drugs.
For this reason ,Jefferson 's drug design programs have attracted
the atte ntion of a number of pharmaceutical companies and
investment groups which have already expressed strong interest
in working with Jefferson to commercialize these drugs. "The
drug design research carried out at Dr. Huang's laboratory
represents the type of broadly applicable platform technology
that is parti cularly well sui ted for collaboration with indust ry,"
notes jussi j. Saukko nen, M.D., Dean of the College of Gradu ate
Studies and Vice President for Science Policy , Technology
Development, and Intern ational Affairs. "The involvement of
the pharmaceutical industry will not only facilitate the
development of comme rcial products, but also provide
imp ortant finan cial support to further expa nd the basic research
at Jefferson ."
"This is ano ther case substant iating the fact that prog ress in
scie nce is not mad e witho ut risk," observes Joseph S. Gonnella,
M.D., Dean of Jefferson Medical College and Senior Vice
Presid ent for Academi c Affairs at Thomas Jefferson University.
"The univ ersity has mad e a hu ge inves tment in translational
research of which th is effort is a major part . And it is paying off.
This approach will not only save prolonged trial and error and
bring benefits to the pat ient that mu ch sooner, it can also be
expec ted to bring rewards to the un iversity in increased clini cal
trials and stronger relati onships with indus try."
In just two years Jefferson 's Drug Design Program has gen era ted
a pept ide drug for human clinica l trials and several organi c
molecules in the pipeline to be deve loped into second
generation of cost-effective, ora lly administered drugs.
Most imp ortantly, the technology developed from these studies
will have general applicati on for developing new medicines for
other human diseases. Rational drug design will playa
prominent role in Jefferson's mission to lin k basic research and
pati ent care. "Jefferson is fortu nate to have such a dedicated and
talent ed drug design team ," says Paul C. Brucker , M.D.,
University Presid ent. "I look forwa rd to the futur e development
of these translati onal research efforts ."
Feature by Malcolm Clendenin
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Technology Transfe r
e erson' k Be een Researc +
Johnj. Gartland 5'44
Since its foun ding , Jeffe rso n Medical College has earne d areputatio n for clinical exce llence and for producing good
doc tors . Prior to 1980, exce pt for a few bright spo ts like the
Cardeza Founda tion, spo nso red research had not been a
prominent activity at Jefferson . During the early I980s, the
Board of Tru stees of Th oma s Jefferson University
reco mmended that the base for Jefferson 's excellence be
broadened by increasing the research effort. Th e Strategic
Plan adopted by the Board of Tru stees in 1982 recommend ed
a concerted effort be made to broaden the research mission at
Jefferson, and addi tional capital for the needed faculty and
for the needed facilities was ap proved. This recommend at ion
and the additional financial sup po rt prese nte d Dean j oseph S.
Gonnella , 1.0 . with a ma nda te to rec rui t more resea rch-
orien ted faculty while , at the same time , to maintain
Jefferson's rep uta tion for clinica l exce llence. In sho rt order,
Drs. Emanuel Rubin , Darwin Prockop, jouni Uitto, and
Willis Maddrey, amo ng others, jo ined the Jeffe rso n faculty
and formed a research focus whic h , in turn , attracted more
research people and more research do llars .
There is general agreement among medica l research ins titu -
tions that success in an ins titu tion's research mission is
meas ured bes t by its share of research dollars obtained
th rou gh competitive awards from the National Institutes of
Health (NIH). In 1985 Jefferso n obtained five million dollars
in NIH fund ing and ranked 78th in research funding awards
amo ng u.s . medical schoo ls. By 1995,Jefferson had
increased its amount of NIH funding to 46 million dollars
and its research ranking among U.s . medical schoo ls had
rise n to the 36th posi tion . The success of Jeffe rso n's research
effort can be understood by considering the rate of increcse of
its share of total fundi ng by the IH.Jeffe rson is seco nd
among all u.s . medical schoo ls in the rate at which its
portion of total Ll.S, resea rch funding has grown over the
period 1985-95.
The results of good medically orie nted research is scie ntific
achievement which can result in discoveries to improve
patient care , or in technologies and produc ts with marketable
possibilities. The link between research and pat ient care at
Jefferson is the Office of Clinica l Tria ls (see pages 9-10) . The
link between research and indust ry at Jefferson is the Office
of Techno logy Tra nsfer whic h deals with patents and licenses
of new discove ries or inventions of faculty or staff. Jefferson 's
link to indu str y began to be forged on an ad hoc basis in
1980. The first uni versity patent policy was formulated in
1982, and establis hment of the Office of Technology Transfer
followe d in 1984 .
The commercial aspec t of a Jefferson discovery or inventi on is
handl ed by the Office of Techno logy Tra nsfer. This pro gram
was created at Jefferson to capture the opportuni ties in basic
and clini cal research and to develop them int o marke table
products in a timely manner. The development of medi cal
technology is a length y process, extending from the basic
discovery through the developm en t of products . Thi s is
followe d by laboratory test ing, clinical tria ls, regulatory
approvals, and finally commercial introduction. Taking a
technology or product from a basic idea to an actual product
that can benefi t the whole population is a task whi ch may be
accomplished bes t by combining the research and clini cal
capabilities of a un iversity like Jefferson with the produ ct
developm ent , manu factur ing, and marketing capabilities of
indust ry. The technology transfer program at Jefferson seeks
to facilitate th is development by secur ing patent protect ion to
give indus try the ince ntive to invest significant resources in
developm ent. This is followed by either licensing the
tech nology or product to an existing company, or to a new
company formed specifically to deve lop the new Jefferson
technology or product.
Abram M. Goldfinger , Director, Office of Tech no logy
Transfer , has an electrica l engineering degree from M.I.T., an
M.B.A. degree from the W harto n Schoo l of the University of
Pennsylvani a, and an indust ry background in research and
development. He began at J efferson in 1987 as a busin ess
venture analyst in the Office of Technology Transfer and was
made Director in 1991. He likes what he does at Jefferson
because it combines science and technology with business,
whic h is a good fit with his educational background . He says
that wor king with Jefferson researchers to see busin esses
crea ted and produc ts developed based on that research is
rewarding. Assistant Director Richard W. Miller has a
bachelor 's degree in bio logy and a Master's degree in
manage ment and experience in the biotechnology and
phar mace utical ind us try. Administratively, the Office of
Techno logy Transfer reports to jussi j. Saukkonen , M.D.
who , in addi tion to being Dean , College of Graduate Studies,
is Vice President for Science Policy , Technol ogy
Development , and Intern at ional Affairs. Dr. Saukkonen has
Sign-o ff autho rity on all commercializa tion agre ement s
negoti ated by the Office of Techno logy Tra nsfer. In add ition ,
Gerald Litwack , Ph.D., Assoc iate Dean for Scientific Affairs,
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mu st approve agreem ents involvin g resear ch at Jefferson .
All legal agree me nts put together by th e Office of Technology
Tra ns fer are reviewed by University Counsel before bein g
signed.
In addition , the technology tra nsfer effort at Jefferson receives
ove rsigh t both from th e uni versity and th e Board of Trustees.
Th e Biotechno logy Co mmittee of th e Board of Trustees was
formed speci fically 10 ove rsee the University's effort s and
ac tivities in thi s area. Th is comrniuec determines how
aggressive a posture Jefferson sho uld tak e in th is area, offers
advice and se ts poli cy on suc h acti viti es as th e formation of new
compa nies and the taking of equity in new co mpanies. Th e
Technology Transfer Adviso ry Committee, a universit y
mana gem en t committee, is main ly advisory in funct ion to
ens ure that Jefferson's technology transfer efforts are conducive
to the gene ral welfare of th e university and are consisten t wi th
othe r uni versit y objectives.
Jefferson 's cur ren t parent poli cy s tipulates that th e universit y
ow ns the rights to any inve ntion mad e or developed with
un iversity funds, equipme nt, facilities, or personnel. University
ow ned technology may be pat ent ed and licensed eithe r
excl us ively or non -exclusivel y. The inventors receive a sha re of
the incom e deriv ed from suc h licenses, and th e remainder is
applied to resear ch and educational purposes at th e Univ ersit y.
Copyrigh table works created for university purposes in th e
course of th e creato r's employme nt also are owned by th e
uni versit y and licensed th rough the Office of Technology
Transfer.
The Unive rsi ty Patent Co mmincc plays a role in the
interpretation and impl em ent at ion of th e pat ent poli cy. Cha ired
by Dr. jussi J. Saukko ne n in his capacity as Vice President for
Science Policy and Tec hno logy Development ,
th e Committee membership represent th e faculty and th e
administration and are appointed by the University Presid ent.
Abra m Go ldfinge r explains how th e technology transfer pro cess
wo rks at Jefferson . AJefferson research er notifi es th e Office of
Tec hno logy Tra nsfer of th e development of a new technology or
product which th e research er believes has co mme rcial possibil-
ities. The first step for th e Office of Technology Tr ansfer is to do
a market ana lysis and rev iew the patentability of th e technology
or product. If these reviews are favorabl e, Mr. Goldfinger files
for a patent. While it lak es abo ut three yea rs to obtain a patent ,
Goldfinge r points out that th e act of filing for a pa tent
establishes a proprietary position for Jefferson whi ch can be
licensed . Nex t, th e Office of Technology Transfer identifies
companies with the appropriate resources to collaborate with
Jefferson in th e development and market ing of th e technology
or pro duc t. Pickin g a compa ny as a partner in th e venture may
hinge on whe ther th e compa ny dem ands an excl us ive co ntrac t
or will acce pt a non -exclusive co ntrac t with Jefferson . If an
existing co mpany is se lec ted to develop th e technology or
product , Jefferson gets licensin g fees and royalti es and, possibl y,
research funds. Jefferson may decid e that the best way to
develop the technology or product is to seek the formation of
a new co mpany. In th at eve nt, th e Office of Tec hnology
Transfer develops an outline of a busin ess plan and
approach es venture capital firms or othe r investmen t groups
to form the company. Jefferson gene rally does not invest
funds in th ese ventures but , once a new co mpany is formed,
Jefferson receives equity in the co mpa ny and , frequently ,
add itio na l research funding.
Abram Go ldfinge r cites two recent exa mples of taking a
Jefferson discovery to market. A vec tor system for gene
th erapy was develop ed at Jefferson whic h is capable of
correc ting errors in the DNA sequence , thu s it may be
broadly useful for gene th erap y as well as in other applica-
tion s. A pa tent applicati on was gran ted in 1996. License and
research agreeme nts were signed in 1994 with Kimeragen ,
Inc., cwtown, PA, a new compa ny form ed to co mmercialize
thi s technology. Th e agreem ent with the uni versity includes
Jefferson receiving equity in Kimeragen , Inc.
Th e second exa mple invo lves a cancer vacci ne which was
develop ed at Jefferson for trea ting melan om a and other forms
of cancer. Th e vacc ine uses a pati en t's own tu mor cells which
are irr adi ated and mod ified to stimulate an immune response
against othe r tumor cells. Clin ical trials have bee n conducted
in over 200 melanoma pati ent s at Jefferson . After surg ical
removal of the tumor, the vaccin e treatment inc reased the
percent age of pati ents rem aining disease-free for four years
from 20 percent to 60 percent. A patent on th e tech nology
was issu ed in 1994 . License and research agreements wer e
signed in 1995 with Avax Tec hno logies , Inc. of Kansas
City, Missouri , a new co mpa ny forme d to commercialize
th is technology. Jefferson rece ives equi ty in th is company.
echnologies developed at Jefferson during 1995- 96
spa nned a broad ran ge of biom edi cal disciplines.
Pharmaceuticals were develop ed which may prevent or treat
major diseases, including multiple sclerosis, rh eumatoid
arthritis , fibrosis, heart disease, cance r, AIDS, stroke and
malari a. Medica' devices were develop ed for a variety of
applica tions , includi ng cathe ters for d iagnosi ng and treating
heart disease, sys tems for imp roving th e quality of x-ray
machines and othe r imagin g equ ipme nt, improved surgical
instruments as well as sys tems to help restore proper
fun ctioning of th e heart and blood vessels, provide speech
and mobility, and repair skin and cart ilage. Diagnostics were
devel op ed to provide earlier detection of so me diseases.
Jefferson resear ch ers have developed more sensitive methods
to determ ine th e presen ce or ex tent of prostate, co lorectal ,
and cervica l cance r, smoo th mu scle tumors, AID ,
ort ho paed ic infections, and hepat itis B, as well as to localize
in terna l infectious foci. Tumo r suppresso r genes whi ch playa
ro le in a number of the most freque nt types of cancer wer e
identified , and wh ich may allow th e develop ment of new
treatments for cance r. Finally, reagents we re developed 10
sto re and cultivate ce lls, including blood co mponent for
continued Oil page 10
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Clinical Tria ls
+
) olln j. Cart/and 5'44
he initi at ive s tarted during th e 1980s to streng the n and
increase th e resear ch effort at Jefferson has resulted in an
investme nt in outstandi ng sc ient ific talent and mod ern
research faciliti es that has enabled Jefferson to be recogni zed
now as a leading medi cal resear ch cente r. This resear ch
in itiativ e also has resulted in th e dev elopment of an infras-
tru cture at Jefferson whe re teams of recruited basic sc ient ists
with outstanding reputations co mpleme nt Jefferson 's acclaim ed
clinicia ns . The result ing co llabo ra tion between basic scient ists
an d clinicia ns enables Jefferson to tak e research breakthrou ghs
from th e laboratory and quickl y translat e them into pati ent
care ben efits , ln thi s da y and age , innovative clinical research
performed at acade mic medi cal centers mu st involve collab o-
ra tion between basic scie nt ists and clinicians.
One part of the co mprehe nsive plan env isioned by Dean
Joseph S. Go nne lla, M.D. to ens ure Jefferson 's fu ture as a
lead ing acade mic medi cal research center is to take advantage
of thi s new collabo rative relati on ship by increasing th e amount
of clinical trial s ac tivity carried out at Jefferso n. The adminis-
trative and sc ientific lead ership at Jefferson is committed to the
expansion of clinica l trials because th ey represent th e link
between resea rch and pati ent care at Jefferson. Assoc iated with
th is ini tiative is th e foste ring of innovativ e relationsh ips with
pr ivate sec to r orga nizations for th e explora tion and evalua tion
of new compounds and devices to improve pati en t care.
The strengtll of these new innovative relationships is built
on jeffe rson's ability to access ti,e large patient populations
necessary to conduct Phase III clinical trials tllmug/l its
partnerships sucll as the j efferson Can cer Network, ti,e
j efferson Healtll System, and ti,e Medical Cent er"of Delawar'e,
among others.
The first step in making a s treng the ned clinical tria ls activity a
reality at Jefferson was to build th e campus infrastructure.
Dean Go nne lla chose Gerald Litwack , Ph.D. as the architec t for
th is effort . Dr. Litwack, a noted researche r in his ow n right ,
was Cha irma n of the Department of Pharm acology at the tim e
of his selec tio n. He is now Cha irma n of th e newly co mbined
Department of Bioch emi stry and Molecular Pharmacolo gy and
Assoc iate Dean for Scient ific Affairs. Dr. Litwack began by
restructuring th e former Office of Resear ch Administra tio n
into a new entity , the Office of Scient ific Affairs whose
major area s .of responsibi lity are l ) research administra tion,
2) clinica l trials, 3) corporate/i ndus trial relat ions,
4) misconduct in research, 5) rese arch sa fety, and
6) gove rn me nt liaison .
Resear ch ac tivity arisi ng out of a sc ien tific discovery, suc h as a
clinical trial , is adminis tere d by the Office of Scien tific Affairs .
Th e division of Research Adminis tration in the Office of
Scientific Affairs signs off on all clinica l trials con tracts. Th e
Institu tional Review Board (I RB) also co mes un der the
Research Administrati on divi sion of the Office of Scie ntific
Affairs. Th e IRB is charged with th e fed erall y mandated
resp on sibility for review of all pro tocols invo lving human
subjects. The Office of Scien tific Affairs wo rks closely with the
Office of Technology Tran sfer and wi th the Office of
University Co unse l in arrang ing industri al co ntracts and
agreement s. Admi nistratively, th e Office of Scient ific Affairs is
part of the medi cal college and reports to Dean Go nnella .
Because clinical tr ials were planned to be a major focus of the
Office of Scien tific Affairs , Dr. Litwack selected Jo hn J .
Schrogie, M.D. , a clinical ph arm acologist and founder and
CEO of the Phil adelphia Assoc iation for Clinica l Trial s
(PACT) , to direct th e clinical trials office wi thin the Office of
Scientific Affairs. This office deals directl y with ph armaccu-
tical co mpa nies , answers their qu esti on s, addresses the ir
co nce rns , and becom es th eir facilit ator in inst itu ting clinical
trials at Jefferson . Drs. Litwac k and Schrogie , together with
Tho mas Murray of th e Clin ical Tria ls Division , developed an
att rac tive handbook which high lights Jefferson 's centers of
exce llence and clinical faculty, their research int erests , and
their past ex pe rience or potential expe rience in test ing new
drugs or devices with pati ents in clin ica l se tt ings. This
handbook , which explains the depth and breadth of Jefferson 's
ex pe rt ise and capa bilities in conducting clinica l trials, was
mailed to 250 ph armaceutical co mpanies and contract
research organiza tions to enco urage them to match the ir
needs with Jefferson's capable clinicians and basic scien tis ts.
ln addition , visits wer e mad e to acade mic institut ions with
experience and success in co nduc ting clinica l tr ials in ord er to
learn from th eir mistak es and from th eir successes. As Dr.
Litwack ex plains , th ese efforts are a ma tter of educating these
compa nies about Jefferson 's capab ilities in providing a site for
their clin ical trials , and then bein g able to deliver caml ess
se rvice at co mpe titive rat es.
Additio na l space for research faci lities was secured by the
recent j efferson purch ase of th e former Western Union
Build ing at 11th and Locust Streets . Anot her piece of the
clinica l research infrastruc ture on campus is the new Clinical
Research Center on th e 11th floor of the Tho mpson Building.
Th e center, under the curren t directi on of Scott A. Waldman ,
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M.D., Ph.D. (see page 21), is an organiza tional component of
the Department of Medicine and possesses the faciliti es and
staff to provide the inp atient and outpatient resources needed
to accomplish clinica l trials. Representatives from companies
interested in pursuing clinica l trials whic h would be
appro priate for the Clinical Resear ch Cente r are given tours of
the facility. If appropriate, th ey are then put in touch with
interested faculty memb ers to develop a suitable protocol for
the proposed clinica l trial.
The clinica l trial s division at j efferson has been organized to
provide researc h sponso rs with a single office for assistance in
iden tifying investigato rs whose clinica l trial int erests,
experience, and pat ients match the study require ments of
their protocols. As Dr. Litwack point s out, clini cal trial s now
are becoming a big busin ess in this country. It is difficult for
mos t medica l uni versities to be compe titive in attr acting
clinical tria ls because of their associated overhead . Th e effort
put forth to da te by j efferson to become more involved with
clinical trials has helped them becom e more competitive in
this marketpl ace. Most of the effort to date has been directed
to contrac t research organiza tions and pharmaceutical
companies. A contrac t research organization is a private or
public clinical research organization that acts as a middle
man, a broker, or a clearing house in clini cal trial activities .
They are used mainly by phar mace utical companies to arrange
for clinical trials because they usually have good scient ific
contacts, and can set up single-center or multicenter tria ls.
They also monitor the progress and conduc t of the clin ical
trial. egotiating with a single clinica l trials office, suc h as the
one at jefferson, is an attrac tive incen tive for cont rac t resea rch
organizations and pharmaceuti cal companies , particularly
after their represent atives have been given a tour of j efferson 's
facilities and sensed jefferson's capab ilities.
Dr. Litwack explains how the clini cal trial pro cess works at
jefferson. A prop osal for a clini cal trial is received by the
clinical trials office. The pro posa l details wha t the sponso ring
orga nization wants to acco mplish and spec ifies the number
and type of patients needed for the trial. Th e office of clini cal
trials ident ifies faculty clini cal researchers whose interests
correspond wit h the needs of the prop osed trial and who may
be willing to participate. During the negotiati on pro cess, one
part icular faculty researcher is identi fied by the invo lved
department , or the department cha irman, as the Prin cipa l
Investigator (P.I.) . The P.l. develops a budget for the prop osed
clinical tria l and submits it to the prop osin g contrac t research
organiza tion or ph arm aceutical company. Thi s budget also
includes all dir ect cos ts incurred by the Investigative Drug
Service , a func tion of the Pharmacy and a service that is useful
in many Phase I and Phase II clinica l trials. j efferson charges
25 percent of the direct cos t of the clinical trial as its indi rect
cos t. If the submitted budget is accepted by the sponso ring
orga nization , the involved individua ls se t up their own
process and ini tia te the clinica l trial after receiving approval
from the Institutional Review Board . After the clini cal trial
begins, the clinica l trials office has onl y a helping and advisory
function . Th e clinical trial inves tigators have the responsibiliti es
of understanding the treatm ent protocol of the clini cal trial , of
following the clinica l trial guidelines faithfully, and of reporting
the results of the clinica l trial scrupulously.
Dr. Litwack believes the clinical trials ini tiative is going well at
j efferson . He says the office of clinica l tria ls often receives two
to th ree new prop osals per week. He explains that Phase I
clin ical trials test the effects of new products on norm al people
to look for possibl e toxic reactions, while Phase II and Phase 1Jl
clini cal trials test the effects of new products on a class of
patients with a specific disease or disorder. Budgets for Phase II
and Phase 1Jl clinica l trials usually provide a source of funding
for the involved clinical researchers. While the details of
speci fic clini cal trials are confidential un til the tria l is
completed , Dr. Litwack says that the clinical trials now ongo ing
at j efferson invo lve a wide variety of large and small pharm a-
ceutical companies, and includ e suc h diseases and disord ers as
stroke, AIDS, cancer, including breast cancer, gastroin testinal
disorders and rheumatoid arthritis . He points to a pile of
between 10 and 15 new clinica l tria l applications awaiting
pr esentation at the next meeting of the Inst itut ional
Review Board.
The mandate given to Dean Gonnella in 1982 to increase
j efferson 's prominence in research and his comprehensive plan
to fulfill that mandate appear to have been successful. The fruits
of this effort have spread j efferson's reputat ion worldwide, have
brou ght addi tional patients to jefferson, and have been a source
of additional funding. During fiscal year 1996, in addition to
NIH research awa rds , j efferson received 12.5 million dollars
from corporate research funding and clinical trials revenu e. The
alumni can be assured that jefferson's future as a leading
academic medical center and as a medical college that graduates
good doctors with exce llent clinical ski lls now is brighter
because of the organized and effective way th is research
initiative is being implement ed.
Te chnology Tra nsfe r , from page 8
transplantat ion . A varie ty of cells whi ch are useful for research
purposes also were developed.
Over the past two and one-half years , 10 new companies were
crea ted based on techno logies developed at jefferson ; these are
compa nies in which the university has or will receive equ ity.
Twenty Ll.S, patents were issued to the university during fiscal
year 1996 , a 67 percent increase over fiscal year 1995. In 1995,
j efferson ranked 29th of all U.S. universities in patents issued.
During fiscal year 1995-96 corporate support for university
research amounted to 11.4 million do llars, in addition to 1.75
million dollars received from licensing revenues. Viewed from
the persp ective of 15 years, j efferson's decision to add a research
component to its acclaimed reputation for clini cal exce llence
can be judged to have been a wise one .
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/Jefferson Medical College Alumni Associ ation invitesyou to join a
(c?/Jarfte YO'Cip in C!?.JJI"' 'fj
June 13-21, 1997
An educational getaway: enjoy the beauty of the Burgundy region of France by hotel barge
with fellow Jeffersonians. Hosted by William V. Harrer '62. past Alumni President and
Professor of Pathology. General medical update topics will be presented by
faculty and alumni, led by Jerome J. Vernick '62, past Alumni President.
Clinical Professor and Director of the Trauma Division
Friday. 6/13 Arrive in Paris
This evening, profe ssional
wine and food aut hority
Melba Mauviel will host a
"Harmony in Food and Wine"
dinner at a charming Parisian
restaurant. Thi s unique and
delightful "experience
gastronomique" will prepare
us for our cru ise through one
of France 's most famou s win e
regions. Melba will join us
later in Burgundy to
acco mpany us to some of her
favorite vineyards: Pornmard,
Meursault, uit s
St. Georges.
Saturday. 6/14 Travel in Firs t
Class on the TGV express
train to Dijo", disembarl:ing
f or hwdl Continue by motor
coach to our barge. Our
afternoon cru ise to
Lon gecourt-en-Plaine begins
with a champagne welcome.
Sunday. 6/15 Monr ing Cruise
to Lovel)' St. ]ean-de-Los"e
After the morning cru ise to St.
j ean -de-Losne we will driv e to
nearb y Dole for a walking
tour.
Monday. 6/16 Tour of Beaune
The river Saone brings us to
Verdun-su r-le-Doubs, where
we board a motorcoach for
wo rld-famous Beaune, capital
of Burgundy'S wine region.
After a tour of Beaune and its
15th-century hospi ces , we
return to the barge.
Tuesday. 6/17 Cruise to
Chalon-sur-Saone After a
morning cruise to Chalon-
sur-Saone, we embark on a
shore excursion to Dijon. A
tour shows us the historic
city cente r, with time to
browse in Burgundy'S largest
open market. Return to the
barge for lunch and an
afternoon cruise to Chagny.
Wednesday. 6/ 18 Arriving at
Chagrl)' The heart of the
Burgundian vin eyard s,
toda y's excursion shows us
the area where 12th-century
monks first set up their
pr esses. We also visit a win e
wholesaler to tast e some local
vintages on tap .
Thursday. 6/19 St . Leger-sur-
Dheune (Cruising) We visi t
the fortress of Rully , private
castle of the Comte d'Aviau
de Ternay. Back at the barge,
we gather for a farewell
dinner tonight, our last on
board.
Friday. 6120 TG Vexpress
bad: to Paris We connect
with TGV express back to
Paris , arriving early
afternoon. Overnight in
Paris.
Saturday. 6121 Bach to U.S.
An extra day in Paris can be
arranged for tho se wishing to
extend their French
experienc e.
Rates The rate of $3400/perso n includes: in Paris, two nights
lodging with buffet breakfasts and special win e tasting/dinner,
hotel tran sfer to train station, round-trip first-class TGV, Paris-
Dijon , all transfers to and from barge, acco mmodations, breakfast,
three-course buffet lun ches, four- to five-course dinners, all bar
drinks and unlimited wine with meals, morning coffee, afternoon
tea, all excursions and entry fees , use of bicycles while barging, all
taxes. The tour is organized and esco rted by Adri Peacock , Ph.D.
in Romanc e Languages and French, travel specialist since 1981.
Air tran sportation between u.s. and Paris is NOT included.
Round-trip airfare from Philadelphia depart ing june 12, 1997 will
be approximately $585.00. Comprehensive travel insurance is
recommend ed.
I) Reserve Now for the Trip
Contact: Adri Peacock , Travel Specialist
Routes de France Travel , Inc.
4839 Olm os Street , El Paso, TX 79922
915 -581-6913 or FAX 9 15-587 -5725
Reserve NOW. Space is limited. Deposit of $500 per person insures
your place on the barge. Balance of $2900 du e March 13, 1997.
2) Register Now
To register , mail the form below to: jM C Office of CME, Alumni
Trip, 1020 Locust Street M-32 , Philadelphia, PA 19 107. Enclose
),our registration f ee of $250.00 payable to ]MC Office of CME.
For que sti ons regarding Continuing Medica l Educa tion credits,
call thejMC Office of CME at 215-955-6992 or 1-888-j EFF-CME
or fax 215-923-3212.
~ .
Name Class Year or JeffAffiliation __
Guest Name _
Preferred Address _
City Stare __ Zip _
Daytime Pho ne _
o Yes. I am willing to give a one- hour educational presentation.
Thomas IJefferson
Jefferson Medical
University College
World-Class Athlet es
&
Richard Cohen '6 5 Officiates at the Oly m p ic s
Jolinj. Ga rt/and 5'44
efferso n was represented ably during the 199 6 Summer
Olympic Games in Atlanta by Richard W. Co hen '65 who
serve d as Chai rman of the Doping Co ntrol Program for thi s
Centennia l Olympiad . Th e int eresting story of how he achieved
this respo nsible position for the 1996 Summe r Olym pic Games
was shared wit h the Bulletin.
After Jeffe rso n graduation, he comp leted an ortho paedic surgery
residen cy at the Unive rsity of Penn sylvan ia, was board -cert ified,
and in 1970 bega n an orthopaedic and spo rts med icine practice
in orristown, PA. Spurred by an interes t in organizatio na l
medicine and an inte rest in civic activities sha red with his wife,
Dianne, the y bega n to consider the possibility of relocating to
another area holdin g mor e prom ise of growth and offering more
opportuni ties for fulfilling their othe r in terests . After a peri od of
de liberate s tudy, they selec ted Atlanta, GA as their new hom e
and moved in 1972. Dr. Co hen joined a friend from '
Philadelphia in practice in subur ban Atlanta and the Cohen
family remain s convinced that their cho ice of new hom e and
pract ice se tti ng was the co rrec t one for them .
As Dr. Co hen's ortho paedic pra ctice grew, so did the resp on si-
biliti es thrust up on him by others. He se rved as Chief of Staff
and Chief of Ortho paedics at Cobb Hospital and Medi cal
Center, and at the Kennesion e Windhill Hospital, both in
subur ban Atlanta . He served as Presid ent of the Cobb Co unty
Medica l Society and Vice Presid ent of the Medical Assoc iation of
Georgia. Curren tly, he is Vice Cha irman of Geo rgia's delegation
to the American Medical Assoc iatio n and will cha ir the
delegation in 1997. He is a past President of the Geo rgia
Chapter of the American Jewish Co mmittee and served as
Chairman of the Physician Sect ion of Un ited Way in 1988.
His varied activi ties outside of his regular occ upa tion of
orthopaedics brought Dr. Co hen to the atte ntion of Leadersh ip
Atlanta , whi ch he was invited to join in 1981 . Leadersh ip
Atlanta is a ne twork of 2,000 selec ted peopl e with leadership
quali ties betwee n the ages of 35 and 50 years whose so le
purpose is to bett er the life of Atlanta . The gro up meets mon thl y
for an ent ire day to discuss topi cs releva nt to life in Atlanta,
such as race rela tions, the j us tice sys tem, and the media, amo ng
othe rs. Netwo rking within Leadership Atlanta provided the
spar k, commitme nt, and key co ntacts which ultimatel y resulted
in Atlanta's successful bid for the 1996 SLI mmer Olymp ic
Games . Dr. Co hen was appo inte d a member of the Atlanta
Olympic Organizing Committee in 1988, an appoi ntm ent which
signaled his official co nnec tion with the Olymp ic effort .
His real work as a member of the Atlanta Olympi c Organi zing
Co mmittee began after Atlanta was selected to represent the
United States in the bid agai nst other competing countries for
the pr ivilege of hosting the 1996 SLI mmer Olympi c Games. Dr.
Co hen chai red the lcdical Commissio n within the official Bid
Commi ttee for the 1996 Olympic Games. The job of the Medical
Commissio n was to develop the medical concept for the
Int ernati on al Olympic Com mittee (lOC) bid which had to
include details for provi di ng medical care for more than two
mill ion spec tators, 12,000 athletes, 70,000 support personnel ,
and 15,000 media personnel. The resp onsibilities not only
included the med ical care of both athle tes and spec tato rs and
medical care in the Olympic Village , but also mechanisms for
gender verification and dop ing co ntro l of competing athletes.
Dr. Cohe n was a member of the Atlanta gro up sent to Tok yo in
1990 for the final site selec tion to be mad e by the International
Olympi c Committee (lOC) between the six finalists, Toronto,
Belgrad e, Manch ester , England, Melbourne, Australia , Athens,
and Atlanta . To their joy, Atlanta was selected as the host of the
1996 Summer Olympic Games. Like the 1984 Los Angeles
Summer Olympic Games, Atlanta's bid was privately funded.
Th e American TV rights, the city's Southe rn charm, and
Atlanta's presumed ability to make the Games a finan cial
success are believed to have been important factors in Atlanta 's
selec tion. After the joy of success came the realization that now
the hard work began for the Atlanta peopl e. After returning
from To kyo , Dr. Cohe n was appointed Chairman of the Th ird
IOC Wo rld Congress on Sports Sciences and Chairman of the
Dopi ng Contro l Program for the 1996 Olympi c Games, a
respo nsibility which wou ld still leave him some tim e for his
practice.
Dr. Co hen soo n learn ed that the sc ience of modern doping
co ntrol is based on analytical chemistry, an observati on that
necessitated brushing LIp on his kn owledge of biochemistry. He
also learned that most mistakes in doping co ntro l occur during
the tim e between athlete notification and urine collection and
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Dr. Cohen on site at the Games
with David Apple. Co-Chairman
its transport to the laboratory for examination . It becam e
evident to the Dop ing Contro l Committee that the "chain of
cus tody," or the tracking of the urine sample from the manufac-
turer of the samp le collection kit , to the notificati on of the
athlete, to the collection of the urine sample and its transport to
the laboratory, must be made totally sec ure to prevent mistakes.
In addition to employing a local bonded cour ier service for
transport of the ur ine sample to the laboratory, his committee
obtaine d special tamper-p roof containers from England , made
especially for this purpose. The Dop ing Con tro l Program had to
deve lop its own laboratory facilit ies in Atlanta, and also had to
identify local , nationa l, and int ern ational experts to assist in all
the details of adequa te and effective dop ing control. .
Duri ng the Olympic Games , Dr. Cohen's Dop ing Con tro l
Program supervised a total of 23 different Doping Control
Stations and 450 volunteer personnel. Dr. Cohe n explains that
because of the way events are scheduled during the Olympics,
only about 18 of these sta tions operated at any one tim e. A
Dopi ng Contro l Station is where urine is collected from the
athletes and where the "chain of cus tody" is most complicated.
Dr. Cohen says they tested all medal winne rs and, randoml y,
abo ut one in four other athletes. Th ose housed in the Olympi c
Village kn ew of the po licy and were aware of the possibi lity of
being tes ted . After each event , the winners have one hour in
whic h to repo rt to a Doping Contro l Station . Thi s grace period
gives the ath lete sufficient time to atte nd the medal ceremony
and press confere nces. The "chain of cus tody" begins at this
poin t becau se each medal winne r is chaperoned closely after the
finish of the event by a Dop ing Cont rol Escort .
Each Dop ing Contro l Station is staffed by a team of physicians
and paramedical personnel an d each urine collec tion is
observed by a sta ff person. After collec tion, the urine sample is
spli t into two samples, A and B. Each is placed in a tamper-
proof conta iner and put int o a secure transpo rta tion bag. Local
bonded cour iers deliver the samples to the testing laboratory
run by the Smit hKline Beecha m Clinical Laboratory Service.
Urine sample A is then analyzed for stimulants, narcotic s,
diuretics , anabolic stero ids , and pept ide hormones. In addition ,
Dr. Cohe n's committee rent ed three high -resolution mass
spec tro me ters whic h can not only identify min ute amounts of
stero id in a urine sample, but also can ident ify traces of steroid
taken months before. Use of this high-tech testing too l in
Atlanta was an Olympic firs t. The Doping Control Program 's
specific responsibility for the urine samp le ends when the
sample reach es the laboratory.
The resu lt of each ur ine examina tion is reported within 24
hours to the Int ernational Olympic Committee (lOC) Medical
Commission. If the test is positi ve for any banned substance, the
athlete is informed and Sample B is then examined as a verifi-
cation chec k. If sample B is positive also, the ath lete is informed
and given a chance to explain to the IOC Medical Commission
which has the power to impose sanc tions. In past Olympi c
Games , some sanc tioned athletes sought injunctive relief from
sanctions by pleading to local cour ts. Th is never prov ed to be a
satisfactory solution for either the IOC or the sancti oned athl ete
because of variability within cour t systems around the world.
In 1994 the IOC instituted a new meth od for appeals by setting
up an Intern ational Court of Arbitra tion which was used for the
first tim e during the 1996 Games in Atlanta. In ord er to
compete in the 1996 Games , each athlete had to sign an
agree ment not to appeal a sanc tion to a U.s. court but , rath er , to
take his appea l to the new Internat ional Court of Arbitration.
This new appeals process is a totally ind epend ent mechanism
with a main pan el of 150 lawyer arbiters from all over the
world. Each appea ls pan el consis ts of three lawyer arbiters
dr awn from the main panel. Sanc tioned athletes appealing to
this new Court of Arbitra tion can expect a binding decision
within 24 hours.
Dr. Cohe n and his committee hope their efforts during the 1996
Olympic Gam es in Atlan ta will lead to a better doping control
system for future Olympics and for all organized competiti ons.
As Dr. Cohen explains, each country has its own Olympic
Federation which sets the standards and guideli nes for Olympi c
participat ion in its own country. The n, for a single two-w eek
period during each Olympic Games , each international
federation functions under IOC con tro l. Dr. Cohen is hop eful
that the 1996 Atlanta Olympics were a step toward greater
cooperation among the 26 different federat ions. Considerable
variety in standards and guidelines still persists among
competing coun tries and spo rts federations, at least as far as
doping contro l is conce rned. Dr. Cohen believes that the
different federations may become convinced of the advantage of
adopting a bett er doping cont rol sys tem which is mor e
standardized as to details of collection , ana lysis, ancl san ctions,
suc h as the sys tem employed in Atlanta for the 1996 Summer
Olympic Gam es.
13 JE F F E R S O N Medical C ol l e g e A l umn i B ul l et in D e c emb er 19 9 6
7Che Blakings
ofthe
cramp/eat l'husi[ian
j. Edward Ball '36
~linically or iented physicians, wh eth er their time be spen t in
"'" private practice or in clini cal teaching in the halls of medical
academe, come to identify certa in fellow physicians who stand
out from the rest. They possess certa in qu aliti es and attributes
that com mand the respect and admiration of their colleagues.
For want of a bett er term , I have categorized them as "compleat"
physicians, purposely using the old spelling "compleat," after
Isaak Walton's The Compleat Angler (1653).
The principal qualities that cha racterize the "compleat" physician
may be defined and considere d under several headings:
A Permanent Student
A basic attribute of the compleat physician is remaining forever
a student. At the very beginning of his caree r he appreciates that
being a student does not end with gradua tion from medical
schoo l. Thus does he ins ure that the remarkable and never-
ending discoveries, the additions to and the modi fications of
our sum total of kn owledge in the bro ad field of medicin e will
not go unnoted by him .
Inquisitiveness
To assure that he ind eed maintains his student role, the
compleat physician is dri ven by an unquenchable inquisitiveness
and an insatiable curiosi ty. Always, as ph enomena are
encountered clinically or in the laboratory, he is moved to ask,
why have these ph enomena developed? How do they arise? By
what mechanisms? He is fully aware that all of us command the
same serving men of whom Rudyard Kipling boasted:
I keep six hon est serving men
(They taught me all I knew).
Their names are What and Why and Wh en
And How and Wh ere and Wh o.
Alert to Gains from Serendipity
The compleat ph ysician does more than remain an inquisiti ve
student. He is alert as well to ph enomena that appear pu rely
by chance in the course of daily activities- phenomena that he
was not purposely seeking. These, too, aro use his curiosity and
invite his in terest in their origin, mechanisms, and significance.
Adaptedfrom thej oe Henry Coley '34 Lecture delivered by Dr.
Ber/I at]eff erson Medical College. Dr. Ball is Distinguished
Professor and past Cha irman of Medicine at the University of
California, Irvine, School of Medicine.
In a lett er written by Horace Wa lpole in 1754 to his friend ,
Horace Mann, Walpole described how taken he was by a fairy
tale he had recen tly read titled "The Three Princes of
Serendip" (the ancient name of the land changed to "Ceylon"
and presently kn own as "Sri Lanka") . The princes were
distinguished by their un cann y knack of un covering
interesting findings for which they were no t looking. Walpole
felt that this remark able capac ity and its potential deserved to
be inco rporated in some way into the English language. To
serve such a purpose, he suggested the word "serendipity."
Th is sugges tion was adopted and the word is now a fixtur e in
our dictionaries and speech.
The gains from serendipity have adde d important ly, not only
to the depth and breadth of general knowledge, but also to
human welfare. Two outstanding examp les are the observa-
tions of von Mering and Minkowski and those of Fleming.
In the late 1800s, littl e was kn own about the function of the
pancreas. Two inves tigators, von Mering and Minkowski ,
sought to shed some light on this th rou gh a series of experi-
ments testing the influ ence of the pancreas on various
ingested food subs tances. As part of their experimental
app roach , they surgically removed the pancreas in a series of
dogs with the int ent of determining what alterations occurred
in the digestive process as a consequence of having no
pancreas. In a chance postoperative conversation with one of
the animal care takers, the care taker offhandedly commented
about the terrible time he was having fending off flies that
would imm ediately swa rm aro und areas in the ground where
the dogs had just urinated. Von Merin g and Minkowski,
struc k by this, verified the caretaker's observa tion . Suspecting
that it might be exp lained by the presence of some substance
in the urine of these dogs that was attrac tive to flies, they
obtained urine from the dogs and examined the specimens.
The striking findin g that emerge d was the presence in the
urine of large amo unts of sugar. Thus for the first time a
spec ific organ was ident ified as involved in sugar metabolism
and in some way responsible for diabetes mellitu s. Out of this
serendipitous finding ult imately came the identification of the
pan creatic islets and the extrac tion from them of insulin.
The gain from serendipity made by the British microbiologist,
Alexander Fleming, is likewise notable and exciting in its
genesis. In 1929, Fleming examined a culture he had
prepared of a viru lent bacterium. He was dismayed to find
that the culture had been contamina ted by a mold whos e
overgrow th rendered the culture of littl e value. Just as he was
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about to discard it , however, he happened to note that
wherever the mold grew in abundance , there were no
evident bacterial colonies.
To find some explanation for this phenomenon, he harvested
the mold and prepared a pure culture of it in a broth
medium. He then inoculated the broth culture of the mold
with the bacterium that he was studying and found that
bacterial growth was markedly inhibited. This suggested to
him that some substance within the mold passed into the
broth culture and suppressed the growth of the virulent
bacteria. Since the class of the mold was "penicillium," he
named the unidentified substance "penicillin ." Thus was
born the antimicrobial era in medicine.
I cannot conclude these remarks on the potential gains from
serendipity without quoting one of the pithy comments of
that great phrasemaker, Yogi Berra of baseball fame: "You
can observe a lot by just watching. " Yogi's expression
probably says it all.
Investigation
The compleat physician is not content to be merely an alert
observer. Inherent in the total makeup of such a person is a
meritorious passion to seek answers to the questions raised
by the phenomena he might purposely or purely by chance
observe. It is of little moment how simple or how minor the
investigative study he undertakes may be. Nor should the
investigative attempt be viewed as nonproductive if the
results are uninformative or non-contributory. Out of the
attempt itself there will be gains with a salubrious effect on
that physician's future approach to the management of his
patients.
The investigative effort will at the least provide a better
understanding of some of the principles of research. Among
these is recognition of the importance of appropriate
controls and the determination of what constitutes
"significant" differences. Also will come appreciation of the
enormous effort and time that is consumed in searching the
literature for previous or related reports, in maintaining
records, in assembling the data, in devising tables and
illustrative material, in writing the report, and in supple-
menting the data with properly arranged references.
If the study should involve a review of hospital records, the
physician will likel y be moved from the experience to be
more detailed thereafter in his own recorded depictions of
the clinical features in a given patient. And the frustrations
he may have experienced in trying to decipher written
records will be apt to make him more sensitive to writing
legibly. Engaging in an investigative effort will also make a
physician more restrained when ordering a medication or a
test ; he will be more inclined to make certain that the
information to be gained, or the benefit that may ensue
outweighs the attendant risks.
It is a commonly held belief that research of any valu e
requires a fully equipped laboratory, sophisticated and
complex equipment, and a host of technicians with special
skills and knowledge. To the contrary, simple, inexpensive,
extremely modest clinical research carried out entirely alon e,
without benefit of supporting personnel and sophisticated
equipment, may nevertheless contribute worthwhile
information.
Consider the example of William Beaumont , dubbed by
Osler the "backwoods physiologist. " Beaumont was an Army
surgeon stationed in 1822 at Fort Crawford, a remote post
along the upper Mississippi . It fell to him to care for a
trapper named Alexis St. Martin who had accidentally fired
his rifle into his abdomen. Under Beaumont's patient care, 51.
Martin recovered but was left with a fistulous opening in his
abdominal wall that communicated with the stomach and
through which the interior of the stomach could be seen.
Even though working alone , without previous experimental
experience, and devoid of the paraphernalia that an investi -
gator at that point in time would be expected to possess,
Beaumont nonetheless set about observing and testing the
digestive capacity of the stomach in St. Martin and carefully
recorded his numerous observations. He even aspirated the
gastric juice and verified that it was acidic.
For years he compiled and recorded careful observations, but
refrained from submitting them for publication in a medical
journal for fear they would be rejected or ridiculed. Wh en he
was finally persuaded to allow them to be published, some
16 years after the accident, he almost immediately attained
international fame and won an honored and permanent place
in medical history.
Flexibility
A hallmark of current-day medicine is the remarkable
profusion of new evidence, new insight, new discoveries.
Because of them, physicians must maintain what may be
described as "intellectual flexibility. " They must possess
receptive minds , examining new data and findings criti cally
but being prepared, should these data prove convincing, to
alter, modify, or even discard previously held concepts and
ideas. They must constantly rethink, reappraise , reevaluate,
or un-learn much of what they learned in medical school as
newer information may dictate. Walter B. Cannon, M.D., the
distinguished Harvard gastrointestinal physiologist,
expressed the need for intellectual flexibility in these well
stated words: "We dwell in a world which is not settled, not
stationary, not finally immobilized. Consequently, wisdom
counsels keeping our minds open and recipient, hospitable
to new views and fresh advances" (The Way of An
Investigator, 1945). We must avoid what John Stuart Mill
called "the deep slumber of a decided opinion." Josh
Billings (the pen name of a popular humorist of yesteryear)
also underscored the danger inherent in a frozen mind
or a fixed idea in one of his classical aphorisms: "it 's not
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what we don 't kn ow that gets us into trouble. It's wh at we
know that ain't so ."
Hun lli }
The compleat physician is charac terized by humility. He is the
first to acknowledge that his diagnost ic and therapeuti c
triumphs are no t entire ly of his own making. He is aware and
appreciative of the fact that con tribu tions by others helped
make his own successes possible: the microbi ologist who
identified the respo nsib le organism and assesse d its sensitivity
to various antibio tics; the path ologist whose microscopic
examination of tissu e revealed abn orm aliti es that established the
nature of the disease; the radiologist whose int erpretation of
images provided insight int o the extent and nature of the
underlying disorder ; the endoscopist wh o supplied visual
depictions of dir ectly visualized lesions as well as biopsi es that
aided diagnosis; and the nursing staff whose tend er and devoted
care contri buted eno rmous ly to the pati ent's ultimate recovery.
Attitudes and Relationships with Patients
Tha t medicine is both a science and an art and not a pure or an
exact science soon becomes eviden t to all physic ians who are
clinica lly engaged. one appreciates this more, however , than
the compleat physic ian. All the modern -day, sophis tica ted
diagnostic app roac hes notwithstanding, he does not abando n
the fundamenta ls of a carefully taken history with a reaso ned
clinical interpretation of the sympto ms, followed by a carefully
performed physica l examina tion. He does not succumb to the
current error of "five minutes of history and five days of
testi ng."
The compleat physician is also mindful that certa in elements ,
atti tudes , and feelings deeply influ ence the relat ionship between
physician and patient. Time and again he has noted that open
display of these feelings seems to contribu te more to the well-
being of his patient than do the medications he prescrib ed or
the various other therapeuti c measures he may have employed.
These basic emo tions and attitudes enco mpass "compassion,"
"concern," and "caring."
In the early part of the present century, Francis Weld Peabody,
M.D., Professor of Medicine at Harvard , said in a discourse on
the care of the patient tha t "the secre t of the care of the patient
is in caring for the patient. " These words should be engraved on
the hearts of every physician as they certai nly are on those who
qualify as compleat physicians.
The qui ntessential attri butes of "compassion" and "concern "
are portrayed in the painti ng The Doctor by Sir Luke Fildes . The
scene is set in 189 1. It depicts a physician , garbed in the dr ess of
tha t day, gazing intently at a very sick young girl who lies before
him on a makeshift bed . In the background are a weeping
mother and a conso ling fath er. Strikingly captured by the artis t
are the troubled emo tions churn ing within the doctor:
compassio n and conce rn as he gazes at the sick; frustration and
perh aps even anger at his inability to do anything trul y effective.
Even the most recent of today's medical school graduates could
enter th is hom e-based scene, whip out a syringe filled with a
potent an tibiotic, inject the contents into the sick young girl, and
then leave withou t so much as a consoling word to the
distraught pa ren ts, yet rest content that by the following
morn ing the chance is great that the child will show
improvement. Were any physician to perform in this fashion ,
however, he would , despite the superior effectiveness of his
treatm ent, be far surpassed in human qualities by the frus trated
physician shown in the painting.
All too often physicians must deal with situations in which
every thing cur ren tly kn own or availab le has been tried but
without success. The disord er from whic h the patient suffers
progresses inexorabl y and a fatal ou tcome is inevitable. In such
situa tions, it does not suffice to simply pronounce the
imminence of a fatal outco me and with that to depart , leaving
the distressed family bewildered and emotionally torn . The true
and compleat physician needs no remi nder that in such trying
circums tances he must in some way provide consolati on and
support even though he too is torment ed and emoti onall y
anguished .
Wha t may be the best hu man compassion at such sad times is
illustrated in a little story that I came across som e time back. A
young mother is anxiously awai ting the return of her son from
schoo l. With each passing minute she grows more and more
conce rned. Finally, the young lad appears. Seeing at a glance that
he is uninj ured, she gives vent to her pent-up emotions by
berat ing him for his tardiness. The lad looks at his moth er and
says , "J im's bike broke down and I had to help him. " This
explanation only rekind les the mother's agita ted state: "Help
him ! How could you help him? You know nothing about fixing
bikes." Again the youngs ter looks meekly at his mo ther and says:
"You're right , mom , I don 't kn ow how to fix a bike and I couldn't
help Jim fix his. But, mom , I had to help him cry."
This is precisely wha t the compleat physician will att empt in
such emo tion-draining situa tions. He will try as well as he can to
conso le a troubl ed famil y and friends, and help them cry.
Inscrib ed on the statue of Dr. Edward L. Trudeau, a pione er in
the treatm ent of tubercu losis, is a 15th-century (or perhaps
earlier) folk saying. The last three words su ccin ctly express the
warmth of the compleat physician that I have been attempting to
describe: "To cure sometimes , to relieve often , to comfort
always."
I hope that my young colleagues-to-be will aspire to become
"compleat" ph ysicians. Shou ld you succeed, I would say to
them , in incorporating into your every action those attribu tes
that charac ter ize a physician of this quality, then , at the end of
your caree r, you will have the rewarding satisfaction of knowing
that your life in medicine was a noble one, a contributory one,
one that won for you the love and apprec iation of your pat ients
and the resp ect and admiration of your colleagues.
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Jefferson Health System and Mercy Health
Corporation Forge Major All iance
Mercy HealthCorporation of
Southeastern Pennsylvani a
and Jefferson Health System
have anno unced plans to
form a comprehensive
alliance . Plato A. Marinakos,
Presid ent and Chief
Executive Officer of Mercy,
and Douglas S. Peters,
President and CEO of
Jefferson Health System,
signed a Memorandum of
Understanding betw een the
two health care delivery
systems followin g approval
by their respective
govern ing board s. As a
result of this alliance, Mercy
and Jefferson will form a
new, int egrated , multi-
institutional health network
with broad geographic
cove rage of the Delaware
Valley.
"Through this alliance ,
Mercy seeks to partner with
Jefferson Health System to
enhance and strengthen our
mission ," says Marinakos.
"Our collabo rative efforts
will build on Mercy's 80-
year health care traditi on as
well as Jefferson 's lon g-
standing commitme nt to the
health needs of the
community. Th is includes a
shared commitme nt to serve
all, including those in the
grea test need ."
Health care services offered
by Mercy and Jefferson span
the entire Delaware Valley.
This alliance will enhance
existing programs and
services and create new joint
initi atives through a
separate joint services
organization in order to
meet the health needs of the
region. Alliance initiatives
include program
development in primary
care, ambulatory car e
centers, physician networks,
hom e health, rehabilitation,
behavioral health , long term
care, and managed care .
"Specifically, we will bring
togeth er the compleme ntary
resources of Mercy, whi ch
has its foundations in
community-based
ambulatory and acu te
hospital care services as well
as mana ged care exp erti se,
with the primary, terti ary,
community, and acad emi c
strengths of Jefferson,"
explains Peters. "Drawing
on our expert ise and
kn owledge, we will meet the
challenges faced by the
health care industry with
inn ovat ive pro gramming
so lu tions ."
Th e Mercy-jefferson alliance
will link two of the larger
health care sys tems in the
region including a network
of more than 2,700 hospital
beds and more than 3,000
ph ysicians. As Marinakos
explains, "The purpose of
the alliance is to focus on a
vision of the future of health
care wh ere services are
delivered in very different
ways than they are toda y.
Toward that vision , we will
develop a bro ad range of
joint services including
linking our respective home
health organizations to
create the largest provider of
its kind in the area,
establishing a wid e network
of ambulatory care centers,
int egrating our physician
netw orks, investing in lon g-
term care and chronic care ,
and realigning our acute
hospitals to face th e future
under managed care."
Additionally, it is the
objective of the alliance to
resume an academic affili-
ation between Mercy and
Thomas Jefferson University
in support of resid ency
programs at Fitzgerald
Mercy and Misericordia
Hospitals. Mercy was a
major teaching affiliate of
Jefferson from 1969 to 1991.
System assets will not be
merged , and individual
sys tem identities will be
maintained . Th e
Memorandum of
Understanding calls for
Mercy and Jefferson to
develop a definitive alliance
agreement by April 30,
1997 .
Peters explains, "The
stre ngths of Mercy and the
Jefferson Health System
complement one another.
We are very pleased and
excited to have Mercy join
Jefferson as a major partner.
This alliance creates
tremendous depth of service
and broad coverage, offering
a complete continuum of
care to the Delaware Valley
region."
"Mercy will continue to
pr eserve and expand the
Catholic health care
mini stry of our sponso rs,
the Sisters of Mercy," says
Marinakos. "The Jefferson
Health System philosophy is
consistent with our mission
and values as an organi-
zation. Our cultures and
styles are similar , and
Jefferson shares our
commi tme nt to caring for
the health needs of the
communi ty. Together we
will respond to the future of
health care in crea tive and
proactive ways ."
Schwartz Joins
Pediatric Faculty
EliasSchwa rtz,
M.D. has
been
appointed
Director of
Medical
Research in the Department
of Pediat rics at Jefferson
Medica l College and the
duP ont Hospital for
Children in Wilmington, a
close affiliate of Jefferson. He
comes to Jeff from the
Children's Hospital of
Philadelphia, where he was
Physician-in-C hief and
Chairman of Pediatrics.
Dr. Schwa rtz has written
more than 200 papers on
blood disorders of children,
including the gene tics and
treatm ent of hemoglobin
abn ormaliti es such as
thalassem ia and sickl e cell
disease. He has lectur ed
extensively on ane mia,
bleeding and platelet
disord ers, and the molecular
biology of hereditary blood
abno rma lities . He is a past
Presid ent of the American
Socie ty of Pediatric
Hematology/On cology.
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R SEARCH
Partial Liouid Ventilation Helps
Premature Infants to Survive
Plectin Protein Deficiency is a
Hereditary Basis for Muscular
Dystrophy with Epidermolysis Bullosa
J
eff physicians, in collabo-
ration with pediatricians
from institutions across th e
United States, have discovered
that partial liquid vent ilation,
also known as perlluoro-
carbon associated gas
exchange, leads to clin ical
improvement and survival in
some infants wh o were not
predicted to surv ive du e to
respiratory distress syndrome.
These find ings appeared in
the September 11 issue of Tlve
New England jo urnal of
Medicine.
The research builds up on
previous studies of the
efficacy of liquid vent ilation,
which uses a perflubron liquid
called LiquiVent ® from
Alliance Pharmaceutical
Corp. , San Diego and Hoechst
Marion Roussel. Th e odo rless ,
colorless , and biologically
inert chemical is used to
gent ly expand and oxygenate
lun g air sacs of premature
infants who are in respiratory
distress. By introducin g
LiquiVent ® via glass syringe
int o the infant's endo tracheal
tub e and keeping the
substance oxyge na ted in the
lungs with a vent ilator, the
research team showed that
parti al liquid ventilation is as
effective in infants as it has
proven to be in animals.
"Liquid vent ilation more
naturally simulates the fluid-
filled condition of lungs
before birth," explained co-
author Jay Greenspa n, M.D.,
Associate Professor of
Pediatrics at Jefferson .
The study focused on 13
premature infants (ges tationa l
age 24 to 34 weeks; birth
weight 600 to 2000 gm) less
than five days old with severe
respiratory distress syndrome
wh o had failed convent ional
therapy including sur factant .
Infants were ineligible if they
had conditions that would
int erfere with the int erpre-
tation of ou tcomes or rend er
medical int ervention futile.
Within one hour of
beginning partial liquid
ventilation , oxygenation
improved and ches t
radiographs revealed even
expansion of the lung air sacs.
Infants were weaned to gas
ventilation without compli-
cation. Eight of the 13 infants
surv ived to at least 36 weeks
correc ted gestational age.
"The implica tions of th is
study are far-reaching,"
comme nts Dr. Greenspan.
"We now have further
evidence that partial liquid
ventilation with LiquiVent ®
is a safe, lifesaving option for
premature infants who had
virtually no chance of living
before the advent of
respira tory therapi es."
Dr. Greenspan's contributions
to this study follow years of
his and Jefferson's devotion to
studying liquid ventilation
and other respiratory
therapies. Jefferson was the
firs t Philadelphia-area
hospital to offer extraco r-
poreal membrane
oxygenation (ECMO) , a
surgical bypass procedure
that uses a heart-lung
machine to oxyge nate and
circu late blood . These
previous studies and
breakthroughs mak e Jefferson
an ideal primary site for an
upcoming Phase II study of
partial liquid ventilation.
Researchers from JeffersonMedical College, in collab-
oration with investigators
from the United Kingdom ,
have clon ed and sequence d a
gene which underli es a
subtype of epide rmolysis
bullosa (EB), a seve re,
inh erited , blister ing skin
disease, and which is
assoc iated with late-onset
mu scular dyst rophy. These
findings were published in the
August 1 issu e of Nature
Gcnetics.
Th e findin gs sugges t that a
defect or deficiency in plectin,
one of the protein s involved
in anchoring skin layers,
appears to underli e EB and
muscular dystrophy.
According to j ouni j. Uitto ,
M.D., Ph.D., Cha irman of
Dermatology and Cutaneous
Biology, the study results are
significant becau se they
demonstrate that EB affects
mu scle in addition to the
layers of skin. Th e new
information will allow for
early diagnosis of mu scular
dystrophy in in fants born
with skin blistering as well as
pro vide DNA-based prenatal
testing for the disea se.
The study focused on four
families with memb ers born
with EB and who later
developed muscu lar
dystrophy in the seco nd
decade of life. At birth, these
pat ients were noted to have
skin blisters cha racteristic of
EB. Years later they
complained of mu scle
weakness. Without scie ntific
evidence, a relati onsh ip
between EB and mu scul ar
dystrophy could only be
considered coincident al.
"Our study was design ed to
see if there was a connection
between epidermolysis
bullosa and muscular
dystrophy," explains Dr.
Uitto . "Study results lead us
to believe that EB is a
warn ing sign of muscular
dystrophy in some people
rather than an unrelat ed
disorder."
By studying pat ien ts wit h the
autoso mal recessiv e disord er
term ed epidermolysis
bullosa with mus cular
dyst rophy (EB-MD),
researchers found that
plectin is abse nt in these
people. The absence of
plectin sugge sts that it is the
candida te gene/protein
system for EB-MD mutation
and led investigators to
clo ne and sequ ence the
human plcctin cD A.
As a result of the research
findin gs, women who have a
child with EB-MD are
eligible for prena tal testing
via cho rionic villi sampling
during the ninth week of
their subseque nt
pregnancies.
The study was tru ly a
multinat ional effort , joining
the talents ofJefferson
researchers and invest igators
from the University of
Dun dee; St. John's Institute
of Dermatology, London ;
Quee n Mary and Westfield
College , London; ICRF
Clare Hall Laboratories,
Hert fordsh irc: the University
continues at right
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"Gene Repair" Technology Corrects
Genetic Mutation Leading to Sickle Cell Anemia
RESEARCH
Researchers at Tho masJefferson Universi ty have
demonstra ted a new gene
repair technology that may
hold prom ise as a treatment
for sickle cell anemia and
other diseases by correcting
the DNA mutation from
which they arise . In a
study published in the
September 6 issu e of Science,
researchers led by Eric
Kmiec, Ph.D., Associate
Professor of Bioche mis try
and Molecular
Pharmacology, repo rt the
use of therap eutic sequences
of genes, term ed
chimeraplasts , to correct the
specific point mutation that
causes sickle cell anemia.
Based up on this and othe r
research already underway,
the inves tigators theorize
that chimeraplasty may one
day provide an effective
treatm ent for an arr ay of
diseases that have a similar
genetic basis as sickle cell
disease.
EB,from left
of Marburg ; Citta University,
Cata nia; St. Luke's Hospital ,
Malta; Nagoya University;
and the Vienna Biocenter,
Vienna .
Dr. Uitto 's contribu tions to
this multinati onal effort
follow years of devotion to
studying EB. In 1991 , he
helped identi fy a collagen
gene responsibl e for holding
skin togeth er and linked a
si te on the gene to a form of
EB. This resea rch provided a
founda tion for the EB-MD
study. ,.
Th e team of scientists from
Jefferson 's Kimm el Cance r
Center, Coo per Medi cal
Cente r (Camden, New
Jersey) , and Corne ll
University Schoo l of
Medicin e introduced the
chime raplasts int o blood
cells dr awn from a sickle cell
anemia patient. Sickle cell
ane mia arises from a
heredit ary mutation in
the p-globin gene.
Chimeraplasty correc ted the
mutation in up to 10 to 20
percent of the blood cells in
the sample; a level which
the experts believe can
potentially alleviate painful
symptoms and help to
prevent the sys temic organ
damage caused by th e
disease. Th e research ers
found that the frequ ency of
correc tion in cell samples
was dependent on the
amo unt, or dose, of
chimeraplasts used .
"W ith this gene repair
technique, we hope to
correct the gene tic mutation
in human blood cells in
sufficient quantities to fortify
the population of normal ,
healthy blood cells in sickle
cell anemia pati ents and
reduce the episodes of pain
and orga n damage," says Dr.
Kmiec. "In addition ,
chimeraplasty may represent
a promising new therapeuti c
technique to correc t kn own
mutations that cause other
gene tic diseases, suc h as
cystic fibrosis and Gaucher's
disease."
Fu ture clini cal studies to
evalua te the safety and
effectiveness of
chimeraplasty in sickle cell
pati ents would involve
drawing blood from a
pati ent and then introducing
chimeraplasts into the
blood 's stem cells. Stem cells
are pr ecursors from whic h
the body's red and white
blood cells arise . The
investigat ors theor ize that by
correc ting the p-globin
mutati on in these early stage
cells , the correc t DNA
sequence will be expressed
in all subseque nt blood cells.
Th erapy would most likely
conclude with imp lant ati on
of the cor rec ted cells back
into the patient via a bon e
marro w transpl ant.
Chime~aplasty may be avery Important
development in the field of
gene therapy, which is
divided in to two catego ries.
The first is kn own as gene
augment ation . These drugs
compensa te for the disease
state by incorporating a
correc t copy of a gene int o a
diseased cell, whic h then
expresses the normal protein
and compensa tes for the
deficiency. The seco nd
category, which includes
chimeraplasty, is kn own as
chromoso mal targeting, or
gene cor rec tion. These drugs
aim to correc t or elimina te a
given gene from within the
chromoso me of the diseased
cell. "The ability of any
vector to target a single base
that is inco rrec t in a
particul ar gene is part icu -
larly cha llenging ," says Dr.
Kmiec. "But the effort is
essential because, if
achi eved , it will provide a
number of clini cal
advantages."
One imp ort ant advantage is
that no extra DNA is
introduced in to the cell, so
the gene may be correc ted
within the contex t of its
norm al chromoso mal
enviro nment. Also, gene
correction may requir e fewer
doses , or even only a Single
dose, until an adequate
percent age of cells are
corrected . Finall y, an
immune respo nse to the drug
can be avoided since the gene
that is corrected is a natural
component of the cell.
In sickle cell anemia , the
p-glob in gene mu tation leads
to the produ ction of red
blood cells that are banana-
or sickle-shaped, and rigid in
the presence of low oxygen,
whereas normal red blood
cells are round and flexible.
The odd -shap ed cells may
becom e stuck in the
capillaries, pile up, and cu t
off blood flow to tissu es.
Oxygen depriv ation of tissues
can lead to severe episodes of
pain , known as crises . In
addition, the misshapen cells
only live for abou t 20 days
and are dest royed when
trapp ed in the liver and
spleen. This results in
anemia .
Sickle cell anemia is the most
common form of sickle cell
disease, and affects more than
50 ,000 Ameri cans. Most cases
occur among African-
Americans, although it is also
common among persons of
Arabian , Caribbean, East
Indi an , Medit erranean , and
South and Central Amer ican
descent. Abou t one in every
400 to 600 African-Americans
inh erits sickle cell disease.
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Genetic Discoveries Lead to New Tests for Lung Cancer
Cancer researchers led byAntonio Giordan o, M.D.,
Ph.D ., of Jefferson 's Kimm el
Cance r Institute, believe that
dama ge to Rb-2lp 130, the
hum an retino blastoma-
related gene, may lead to
lung cance r. Cigare tte
smo ke, air pollution , some
toxins breathed by workers,
and othe r enviro nmental
carcinoge ns may cause the
dama ge and inhibit the
body's ability to make the
pRb-2Ip130 protein , a
powerful tumor suppresso r
in humans and mammals.
The inves tigators are already
crea ting a new lung cance r
early detection and tumor-
grading test to enable
physician s to assess how
mu ch protein from Rb-
21p130 is found in indi vidual
lun g cance r pati ents. Based
on the results , clini cians may
begin treatments ear lier and
tailor them according to how
aggress ive the cance r is. Th is
finding , whic h appea red in
the July issue of Clinical
Cancer Research, is the latest
for the Jefferson team and
collaborators from the
departments of ana tomic
path ology and respiratory
disease at the Second
Unive rsity of aples. The
work was funded primaril y
by the ationa l Cance r
Institute ( CO.
"Dr. Giordano's findings
have the pot ential to red uce
mort alit y from lung cance r
significant ly," notes Dr.
Arthur C. Upton , former
Director of the CI and
President of the Ramazzini
Institute. "By identifying the
molecul ar nature of the
changes caus ing cancer in
cells of the lun g, his findings
may lead to tests for the early
detection of such changes and
to strategies for preventing
and for success fu lly trea ting
the disease."
Clinical application of the
researchers' laboratory work,
and the publicati on thi s
spring of Rb-2Ip130 studies in
three prominent medi cal
journals , mark an important
culmination point in the
study of the retinoblasto ma
gene's involvem ent in cancer.
Dr. Giordano has been
studying the gene for eight
years.
"Based on the fact that Rb-
21p130 protein levels
correspo nd with the stage of
lung can cer , a new test to
measure the levels could be an
immediate benefit in
determining how aggr essive
cance r tumors are in
individual pat ients," says
Emanue l Rubin , M.D., the
Apo nte Professor and
Chairman of Pathology,
Anatomy, and Cell Biology,
wh o is collaborating with the
research team on development
of the test.
In a previou s paper in the
May 1 issue of Cancer
Research, Dr. Giordano's team
identified th e gene named Rb-
2Ip130, located on
chro mosome 16, and showed
that it makes a protein that
plays a vital role in controlling
the cell cycle in all human and
mammalian cells. When Rb-
21p130 is alt ered and canno t
produce its protein , pRb-
21p130, the cell may not reach
the natural s tage of
programmed cell death .
Instead, the cell continues to
live and divide ou t of co ntro l
possibl y leading to tumor
formation and cancer.
In tests of various cance r cell
line s, wh en normal (wild
type) pRb-21p130 was
reintroduced back int o
can cerous cells, the protein
interacted with seve ral othe r
prot eins, most notably one
nam ed cyclin A, to block
uncontrolled cell growth by
moving the cell along to the
next stage in its natural life
cycle, whi ch eventua lly ends
in apoptosis. Without the
critical tumor suppresso r
gen e, the cells cont inued to
live and divide.
Th e scientis ts next publish ed
the complete 0 A makeu p
of Rb-2Ip130 in the May 15
issu e of Proceedings oj the
National Academy oj Sciences.
"Since we observed in the lab
that a lack of pRb-2lp 130 may
playa critical role in
prolongin g cell life in a
variety of cance r types,
learning about the gene's
complete geno mic struc ture
and seque nce would even
bett er enable us to
understand how pRb-2Ip130
works so that we could focus
our efforts towards a clin ical
intervention in pati ents to
either prevent them from
developing cance r, or to kill
can cer tu mo rs already
developed ," says Dr.
Giord ano.
A practical oppo rtunity toapply this work to the
diagn osti c realm of cance r
medicin e soon aro se. In the
July issu e of Clinical Cancer
Research, Dr. Giordano's
team descr ibed a study of 77
tumor samples from male
and female patients with
surgically resec ted lung
cancer. Th ey found that the
less the pRb-2Ip130 pro tein is
expressed by a tumor , the
mor e aggressive the lun g
cance r. In normal lung cells, a
high amount of pRb-21p130 is
present. This da ta opens the
door to developing a variety of
tests agai nst the complete
pathogenesis of lun g cance r in
pa tients .
The first type of test sho uld be
widely available wi thin two
years. The tes t will accurately
describe which stage of
cance r, either I, u, Il l, or IV,
that ind ividual pati ents are in ,
base d upon the levels of pRb-
21p 130 that are present in
their excised lun g cancer
tumor. Treatments may then
be tailored accordingly.
Ano ther test type now being
inves tigated aims to anal yze
Rb-2Ip130 in individuals to
determine gene tic suscepti-
bilit y to lun g cancer.
Yet another type of test bein g
investigated will use the Rb-
21p 130 protein as a tumor
marker to learn wh en patient s
have deve loped lun g cancer.
"Using pRb-211' 130 as a tum or
mark er may be an efficient
meth od of co nti nuously
mon itori ng the group of
patients who is at the greatest
risk for lun g can cer before any
morphological changes have
occurred in the lun g," says
Dr. Giordano. "In addition,
the ability to det ermine the
exac t level of pRb-2lp 130
express ion in individual lun g
cancer pat ients may be a
powerful prognostic tool for
ph ysicians to aid them in
de ter mining the most
appropriate treatment
strategy. ow that we
recognize an inverse
correlation between pRb-
21p130 expression and lun g
cance r stage , the questions
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Selective Marker for Metastatic Colorectal Tumors
Will Bring New Methods of Diagnosisare : what levels of pRb-2I1'130
expression show cance r?
And wha t levels of pRb-
211'130 expressio n correlate
with each stage of lun g
cancer? These answe rs will be
found th rou gh a large-scale
screening of patients."
Such a study is now
underway. Th e test , whi ch
will be a sur rogate to
histological grading by a
pathologist , is now under
development in a collabo-
rative effort betw een
j efferson 's Departments of
Microb iology and
Immunology, and Pathology,
Ana tomy , and Cell Biology.
Ano the r impo rta nt
application of a test for 1'Rb-
211'130 may be the ability to
de termine earlier than
previous ly possible susce pti-
bility in groups at risk for
lun g cance r, such as ex-
smo kers and workers wh o
have been expose d to
airborne carcinogens .
Foundry workers and peopl e
who live in highly industri-
alized areas often breathe
high levels of combus tion
products, including
carcinoge ns known as
polycyclic aromatic
hydrocarb on s, whi ch have
been linked to lun g cance r.
Th e Ramazzini Institute for
Occupationa l and
Environmenta l Health
Research is a lon gtime
suppo rte r of Dr. Giordano 's
research . The institute is a
nonprofit organization that
prom otes and coo rdina tes
multination al resear ch and
educa tion.
Sheldo n W. Samuels, Vice
Presid ent for Policy Studies
continues at right
esearchers at jefferson
have discovered that the
protein gua nylyl cyclase C
(GCC) is expresse d in humans
so lely in the int estines,
including the colon and
rectum, making it a selectiv e
mark er for colorec tal tumors
that metastasize outside the
int estines. These findings
appear in the December 10
issu e of Proceedings oj the
National Academy oj Sciences.
Th e research , led by Scott A.
Waldman , M.D., Ph.D. (see
page nin e) , Associate
Professor of Medicin e and
Acting Director of the Division
of Clinical Pharmacology,
is gro undbreaking because
it has the potential to lead to
the first effective way of
detecting co lorec tal tumors
once they migrate out of the
int estines.
of the Ramazzini Institute
and form er chair of the
Committee on Cancer Risk
Assessment of the National
Cancer Advisory Board ,
says, "Dr. Giordano's
discovery may have a
profound impact on the
assessme nt of cancer-
caus ing agents in the
enviro nme nt , by enabling
regulators to measure risks
to populations and
indi viduals from spec ific
doses of gene-damaging
agents at the first stage of
cance r development."
This is the seco nd gene thi s
year that has been linked to
the development of lun g
cance r by researchers at
jefferson's Kimmel Can cer
Institute.
"The survival rat e for pati ents
wh o have metastat ic
colorec tal cance r is presently
very poor , with only five
percent surviving after five
years, becau se there has not
been an effecti ve way of
tracking its spread to othe r
organs and present
chemotherapy do es not mak e
an enormous impact ,"
explains Dr. Waldman.
"Knowing that GC C is
specific to the int estines
allows us to use it as a tag or
marker to det ect wh ere the
cance r has spread."
By exa mining human tissu e
samples with the reverse
transcription-polymerase
chain reaction (RT-PCR),
research ers discovered that
GCC is only expresse d by two
different cells in the body. It
is present in the single layer
of cells that lines the normal
intestine and co ntinues to be
expressed after these cells
undergo mali gnant transfor-
mation and migrate out of the
intestines into other sites. As
a result of thi s, GCC acts as a
marker , demarcating the
cancer's spread through out
the bod y.
GCC is also the recept or for
the heat-stable entero toxin
(ST) produced by E. coli.
With this working
kn owledge, the j efferson
team exposed preparation s of
human tissues to ST and
discovered that the only
tissues that int eract with thi s
small protein were those that
expresse d GCc. Only tissu es
outside the intestine,
containing metastati c
co lorec tal cance r, expresse d
GeC and interacted with ST.
"We found that ST effectively
binds to GCC in all tissues
whic h contained metastatic
co lorec tal cancer, regardless
of the type of tissue or its
location ," says Dr. Waldman.
"It is our hope that this
research leads to new
treatments that use ST as a
guided missile to guide
cance r-fighting poisons
directly to metastat ic tumor
cells, without harm ing normal
surroundi ng tissues."
Targe ted Diagnost ics and
Therapeutics , Inc., a biot ech-
nology com pany which has
acq uired the worldwide
exclusive license to the work
from Dr. Waldman's
laboratory, is laying the
gro undwork for the birth of
new diagnost ic and
therapeu tic op tion s by
developi ng a tissue biop sy test
that will accurately stage
pat ients , to determine if
colorec tal cancer has spread
outside the intes tine . The
company is also developing a
blood test that will determine
if colorec tal cancer has spread
beyond the int estine or has
recurred after definitive
surge ry. In add ition , work has
begun on new therapeutics
which will use ST to target
and kill metastat ic colorectal
cancer cells.
"It is our goal to mak e
diagnost ic tests available for
clinica l use in the next two to
th ree years, reducing the
number of lives color ectal
cance r claims each year ,
which is current ly close to
50 ,000 ," says Har ry A. Arena ,
C.P.A., ~l. B.A., President and
CEO of Targeted Diagnostics
and Therapeutics , Inc.
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HIV-I Integrase Can Be Targeted for Gene Therapy
Research ers in th eDivision of Infectious
Diseases have made two more
import ant discoveries about
the human immunodefic iency
virus (HIV).
HIV- I Envelope Has
Penneable Pores
Researchers have discovered
that indi vidual , biochemi cally
active HIV-l viruses have
perm eable pores that make
the HIV-I envelope
vulnerable to certain
com pounds designed to kill
the virus . These findin gs were
published in Proceedings of the
National Academy of Sciences.
The research , led by Roger J .
Pomerantz, M.D., Professor of
Medicin e, Chief of the
Division of Infectious
Diseases, and Director of the
Cente r for Human
Retro virology, and Hui Zhang,
M.D., Ph.D., research
assoc iate, is groundbreaking
becau se it dem onstrates that
contrary to previous thought ,
the HIV-l envelope is "open,"
allowing researchers to target
and kill each individual virus
with a group of compounds
called nucleosid e analog
triphosphates.
"These compounds have the
ability to pen etrate the viral
envelope, incorporate int o
and dir ectly terminate the life
of the virus, " explains Dr.
Pom erantz. "As a result , viral
infectivity is potentl y
inhibited ."
Demonstrating these newly-
found cha racteristics of the
viral enve lope has led
Jefferson researchers to
pr opose that nucleosid e
analog triphosphates might
also dir ectly act as viruc idal
agents that might be quite
useful in preventing either
heterosexual and / or
hom osexual transmission of
HIV-l. Th ese viruc ida l agents
could be coadministered with
spermicidal agent s. Instead of
onl y killing sperm, this
formula would also kill the
individual HIV-1 viruses
before they becam e infectious.
"It is important to rememb er ,
however , that whil e this
finding is extreme ly enco ur-
agin g, it is not a cure for
HIV-l or AIDS," says Dr.
Pomerantz. "In the sho rt term
it is our goal to use findings
such as these to change AIDS
from an acute disease to a
chroni c, treatable one. "
HIV-l IJIlegras e Can Be
Targeted for Gene Therapy
Jefferson scientists have
discovered that intracellul ar
immunized cells have the
potential to inhibit the
pro gression of the HIV-1 life
cycle wh en used as therapy
during int egrase, the period of
productive viral repli cation.
The se findin gs appear in the
December issue of the j ouruui
of Virology.
The research , led by Dr.
Pom erantz and Drs. Lingxun
Duan and Pnin a Levy-Mintz , is
gro undbreaking because it is
one of the first time that the
integrase area of the viral life
cycle has been targeted for
therapeut ic treatment.
Integrase had been the most
difficult , and is a most
important, stage of HIV- I to
target with therapy.
"Being able to target integrase
molecules, those that carry
HIV-I DNA into host cell
DNA, can ultimately prevent
the HIV-1 virus from spreading
to new cells in pati ent s already
infected with the virus ,"
explains Dr. Pome rantz.
This is the beginning of gene
therapy research at Jefferson
for treatin g HIV-I infection . It
brings basic science from the
bench to the bedside . ,.
Less Radical Treatment May Eliminate Breast Cancer
A study of women with insitu (no ninvas ive) ductal
breast cance r revea ls that
excision and surve illance
alone are an alterna tive to
mastectom y or irradi ation in
treatin g noninvasive breast
cancer. Results of the study
were pr esent ed at the 32 nd
Annual Meeting of the
American Society of Clinical
Onco logy.
The data , collected betw een
1975 and 1994 at J efferson
Medical College , shows that
only 28 of 194 breasts (three
women had bilateral in situ
cancer) treated with excis ion
and surveillance alone had a
recurrence. Th ere was a
mean and median follow-up
of 55 and 53 months, respec-
tively.
During that tim e, only five of
the 194 breasts in 191
women , or three percent of
the recurrences showed
evide nce of invasive (or life-
threatening) cance r,
including microinvasion .
Twenty-three recurrences
were entirely noninvasive.
According to senior aut ho r
and present er Gordon F.
Schwartz, M.D., M.B.A.,
Professor of Surgery at
Jefferson and a specialist in
diseases of the breast , these
findings are contrary to th ose
in most othe r studies to dat e.
"No patient in this gro up has
died from breast cance r since
the study began ," he
explains. "Even if recurrence
does take place, it is most
likely to be the same type of
noninvasive cells as the firs t
time. And in selected cases , a
seco nd, local exc ision may be
suitable instead of irradia tion
or mastectom y."
Women with a confirmed
diagnosis of noninvasive
breast cance r underwent
post-biopsy mammography
to verify excision of calcifica-
tion s. Wide, local re-excision
was performed in most
pati ent s. The maximum
diam eter of calcificati ons
considered sui table for this
treatm ent option was 2.5 em.
"Excision and surveillan ce is
a reaso nable alternative to
mastectom y or irradiation for
selecte d women with in situ,
du ctal breast cancer that
presents nonpalpable calcifi-
cations, or as an incidental
finding ," says Dr. Schwartz.
"A major treatmen t
reco mmenda tion su ch as
radiation or mastectomy may
be withheld un til and if a
recurrence does take place."
Dr. Schwa rtz notes that even
if a recurrence doe s occur, it
is likely to be noninvasive.
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Melanoma Vaccine Clinical Trial
Shows Significant Improvement
in Four-Year Survival
Research
Funding Keeps
Growing
Linear Accelerator
for Radiosurgery
at Wills Eye
Interim results from aclinical trial of a vaccine for
treating melan oma, led by
David A. Berd '68 of
j efferson 's Division of
eoplastic Diseases, show
significant improvement in
four-year surv ival compared
to cur rently available
treatm ent s.
According to the study, whi ch
will be partially disclosed on
May 21 at the annual meet ing
of the America n Socie ty of
Clinica l Onco logy, 62 patients
were treated with a special
vaccine made up in part of
their own tum or cells. Four-
year survival was higher than
a control group of pati ents
treated with standard surgery ,
and higher than patients wh o
recently parti cipated in
studies of the drug alpha
inte rferon.
The vaccine under investi -
gation is being used
postsurgically for treating
advanced , but surgically
resectable, malignant
melan oma . In the study,
patient s with stage- Ill tumors
in the lymph nodes were
trea ted with the vaccine after
standard lymphadenectomy-
an operation whe re the
melan oma and surrounding
lymph nodes are removed . Of
62 pati ent s who received the
vaccine , 47 percent were free
of relapse after four years, and
58 percent surv ived four
years. This is compared to 20
to 25 percent survival in
patient s treated with surgery
alone .
"The melan oma vaccin e is
n1ade from a pati ent 's own
tumor cells, which are
inactivated and modified with
the che mical hapten dinitro-
phenyl. This pro cess makes
the tumor cells appear foreign
to the pati ent's immune
sys tem, and so the immune
sys tem atta cks and kills the
cells," explains Dr. Berd. The
pati ents also receive a low
dose of cyclophosphamide, a
medication commonly used in
cance r chemothe rapy, but
which has been shown to
boost the immune sys tem
wh en administered in the
right way.
An unexpected finding was
the significantly better
survival of older patients in
the study. The four- year
survival of patients over 50
years old was 66 percent ,
compared to 46 percent for
patients under 50 .
Dr. Berd is also researching
the application of this type of
vaccine again st other
carcinomas, such as br east
cancer, colon cancer, and
ovarian canc er. These studies
are scheduled to begin in
about one year.
In recent years, mortality from
melanoma has been
increasin g. In 1995 , the
National Can cer Institute
(NCO expected more than
34,000 new individual cases
of melanoma in the Unit ed
States alone , and expec ted
almos t 7,200 ind ividuals to
die from the disease. The
incidence has increased nearly
80 percent between 1973 and
1987, at a rate of approxi-
mat ely four percent per year,
according to the NCI. II)
J
efferson received a total of
$75.2 milli on in Federal
and non-Federal research
awards during fiscal year
1996 , up from $72.1 million
in fiscal year 1995 . In 1995
it ranked 36th am on g the
124 medical schools in the
United States in term s of
research funding from the
National Institutes of
Health . II)
Critical Care
Trials Group is
Funded by NIH
J
efferson is one of 10
clini cal sites nati onwide
selected to participate in the
Criti cal Care Trials Group
fund ed by the ational
Institutes of Health. "This
marks the first tim e the NIH
has supported a coordinated
group of acad emi c centers to
design and carry out clinical
trials in the areas of acut e
respiratory failur e, sepsis,
and critical care," acco rding
to jonathan Gottlieb, M.D.,
eo-principal investigator and
Associat e Professor of
Pulmonary Medicine and
Critical Care. "As part of the
Critical Care Trial s Group ,
we have the opportunity to
offer our pati ents parti ci-
pati on in the most advance d
treatment protocols, as well
as to enhance our state of
kn owledge." IQ
Physicians at theeurosensory Institute,
Wills Eye Hospital , who hold
faculty appointments at
j efferson Medical College,
are performing brain surgery
with a new device : a linear
acce lerato r specially
designed for stereotactic
radiosurgery to the brain .
With this technology they
are treatin g bot h benign and
malignant brain tum ors,
arte riove nous malforma-
tions, and intracranial
disord ers, non invasively and
on an outpatient basis.
Associate Professor of
Neurosurgery David W.
Andrews, M.D. explains that
the new stereo tactic
treatm ent sys tem delivers
focused radiation in eith er a
single dose, or in multiple
fractions over a period of
days. In either case, the
patient usually returns to his
normal routine within days
and is spared the surgical
trauma and side effects
associated with open brain
surge ry.
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STUDEN Ar'TIVITIES
In addi tion ,JeffHOPE
operates a pat ient education
pro gram in conjunction with
the Greater Philadelphia
Urban Affairs Coalition's job
training program for the
ho meless, and an educational
series for the Jefferson
com mu nity consisting of
speakers, discussion groups,
plays, and movies related to
issues of socia l responsibility
and medical services for the
urban underserved .
JeffHOPE is active in
commu nity and epidemiologic
resea rch, with past and
cur rent projects including an
HIV and tuberculosis
prevalence study; investi -
gation into the demographic
characteristics of the
population the clinics serve;
and research into parenting
and stress among addicted
women. The organization is
also active in curricular issues ,
and last spring instituted a
service/learning program in
whic h five first- or second-
year medical students are
placed in com muni ty organi-
zations for approximately 10
hours per week to assist with
program develop ment and
imp lementation .
JeffHOPE has become a model
for medical schoo ls around
the country. Health profes-
sio nal students and even
resident s volunteer at
JeffHOP E because it provides
them opportunities for
learn ing and service to the
community which are
provided by no other part of
their education . Students from
ot her medical schools who are
orga nizing their own
homeless shelter clinic project
visi t to learn from JeffHOPE
successes.
All the clinics are staffed by
volunteer physicians,
resid ents , medical students,
nurses , nursin g students, and
occupational and physical
therapists. Th ey work
togeth er as a team to provide
health care for the poor and
underserved men and women
of Cent er City. Each week,
physicians, allied health
professionals, and students
pro vide desperately needed
health care at each of the sites,
treating probl ems ranging
from skin problems to
congestive heart failur e.
By redu cing barri ers to health
care and helping these men ,
women, and children to
achieve bett er health ,
JeffHOP E is helping them to
return to mainstr eam soc iety
and to find housin g,
edu cation , and employment.
JeffHOPE (Health
Opportunities, Preventi on ,
and Edu cation) provides
comprehensive health care
through weekly clini cs at
shelters and service sites for
underserved men , wo men,
and children in Philadelphia.
Since January 1993, JeffHOP E
volunteers have been
operating a pr ima ry health
care clini c at St. Columba's
shelter for homeless men . In
Novemb er 1993, the
volunteers established an
additional clin ic at Gateway
Service Center, a city shelter
and day program. A th ird
shelter site opened in
September 1996 at a needle
exchange pro gram site run
by Prevention Point
Philadelphia. Under consider-
ation is a fourth site whi ch
would serve homeless and
ment ally ill wom en in
Philadelphia.
V Financial Support
JeffHOP E is a voluntee r
organization. Th e expansion
of its services and opportu-
niti es has created an
expansion in its operating
budget. Funds are needed to
support its service learning
program , to cont inue its
lecture series, to improve its
pati ent educa tion pro gram ,
and to pro vide administrative
support.
If you would like to help
JeffHOP E to maintain its
successes and expand
its hor izon s, please call the
JeffHOPE office at
215955 1878 .
v Supplies
The clinics are supplied by
donations from Th oma s
Jefferson Universi ty, drug
companies, and private
physician pra ctic es. Th e
clinics need samples of
commo nly used drugs,
dr essing su pplies, office
equipment such as exam
tables , blood pr essure cuffs,
and other medical supplies .
v Time
JeffHOPE runs on the
volunteer time of students
and ph ysicians. We need
local prima ry care
physicians to serve as
preceptors at the clinics, and
specialis ts in Philadelphia
who are willing to accept a
limited number of referrals
from the clinics on a pro
bono basis.
V conducts research into
the health status and health
needs of the populations
JeffHOPE serves
J
effHOPE, the stude nt-ru n
homel ess clini c and urban
health care project which
was featured in the June
1996 Bulletin, welcomes the
par ticipation of Jefferson
gradua tes as well as
students.
V teaches formerly
homeless patients about the
health care sys tem, health
maint enan ce, violence
preventi on , and stress
management
V gives students an
oppo rtunity to pra ctice
their histo ry-taking,
physical exam, and differ-
ent ial diagnosis skills while
providing service to the
community
Alumni Too Can Participate in JeffHOPE
What Does
jefjHOPE Need?
V provides socia l service
information and counse ling
to patients at the clinic sites
V helps Jefferson students,
staff, faculty, and alumni to
educate themselves about
the health problems and
socia l service needs of the
homeless and medically
underserved , and the
broader soc ioeco no mic
issues related to "health"
V provides free, accessibl e
medical care to medically
underserved indi vidu als in
Philadelphi a
What Does
j efjHOPE Do?
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Student AMA Organizes
Bone Marrow Drive
First-year leannlne A.
Weimar-Fitzpatrick
and her mother
Grace Wcimar
Grego ry Gertner, Class oj 2000
On the cover of a pamphle tfrom the National Marrow
Donor Program (NMDP), a
young child's eyes grab the
reader's attentio n. Undernea th
the picture are the word s, "I
need a marrow transplant. Please
Help." The jefferson Medical
College chapter of the American
Medical Associati on is trying to
help . This year, the AMA plans
to conduct its first annua l Bone
Marrow Registration Drive . But
they need your help as well.
An estimated 30,000 children
and adults in the u.s. arc
diagnosed each year with
leuk emia, aplast ic anemia, or any
of over 60 other potenti ally fatal
blood diseases. For man y, the
only hope for survival is a
marrow tran sp lant. Thirty
percent of these pati ent s will
match marrow types with a
family member . This means that
70 percent of marrow transplants
come from unrelated don ors,
and the only way to becom e an
unrelated donor is to regist er
with the MOP. Unfortunately,
there is a significant cos t to
register , and , espec ially at the
medical college level, students
who may be willin g to become
registered with the NMDP are
unable to because they simply
cannot afford it. Th e NMDP,
however , has found a corporate
donor who will match any fund s
raised. This means that any
donation s from you will help
twice as man y students become
registered with the Marrow
Don or Program .
In 1995, the NMDP coordinated
more than 80 transp lan ts every
month . The program cou ld
accomplish even more if its
regist ry of volunteer donors
were larger and more diverse.
There may be somebody hcre
at j efferson who has a marrow
type matching that of a dying
child . Thi s person needs your
help to becom e registered with
the NMDP. Your donation may
allow a medical student to save
a life now , before he or sh e even
becomes a ph ysician.
If you are int erested in helping
the AMA save lives in this way,
please send correspondence to
jefferson American Medical
Association, Medical Stud ent
Section, Attenti on : Steven
Sarkisian, President, 1000
Walnut St., Apt. 2007 ,
Philade lphia , PA 19107. JI
Freshman students Gregory S. Gertner. Ryan I. Zlupko,
Anne M. Nelson. Kcvin I. Hira kawa, Omar K. Yunis
Daniel P. Petro '2000 (right) and his sisler Anastasia. a member of
the Class of '99 (second from left). with their paren ts Paul and
Mal)' Petra at the Reception for Freshman Families on August 21
Jefferson is Reconfirmed as
Delaware's Medical School
Jeff Physicians in the Year 2000
V 223 first-year students mat ricul at ed th is fall at j efferson
Medical Co llege (340 were acce p ted ou t of 11,189 applica nts)
V 71 are fem ale, and 152 are male
V eigh t are members of minor iti es
V 25 already hold master 's degrees , and six hold doctorates
V 22 are part of th e DIMER program for st ude nts from
Delaware (see article at rig ht )
V 21 are in the six-year acce lerated B.S.IM.D. program with
Pennsylvania State Un iversity
V 12 are particip at ing in th e Physician Sho rtage Area Program
which funnels-graduat es to practi ce in underserved areas
A Delaware bill Signed intolaw in July reconfirms
Jefferson's role as the medi cal
coll ege for the state of
Delaware.
Through th e Delaware
Inst itu te of Medical Education
and Research (D lMER) ,
admission to Jefferson is
reserved each year for
students from Delaware.
The arrangement has been in
plac e since 1970 . In lieu of
funding and maintaining a
medical school , the s ta te
develop ed "a coo rdinated
program of pr em edical ,
medi cal , and gradua te
educatio n am on g s tate public
institution s of high er learning,
Delaware hospitals , and
Jefferson Medi cal Co llege. "
Th er e is further give-a nd- take
in that many Jeff s tudents
receive clinical training from
Delawar e ph ysician s at the
Medi cal Ce nte r of Delaware,
th e Wilmington Veterans
Med ical Cente r, or the duP ont
Hospital for Children, a close
affiliate of Jefferson . JI
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New Inflammatory Bowel Disease
Center is Announced
The Raymond C. Grandon '45 Lecture was delivered by Mark
D. Smith. M.D.. M.B.A. (at right above. with David B. Nash. M.D..
M.B.A.. Director of Health Policy and Clinical Outcomes). Dr. Smith
is Executive Vice Pres ident of the Kai ser Family Foundation. and
past Executive Director of the Philadelphia Commission on AIDS.
The next Grandon Lecture will be May 15 at 8:00 A.M. in DePalma
Audito rium: the speaker will be Karen lgnagnt. President and CEO
of the American Association of Health Plans.
B a OKS
ALS Diagnosis
Jerry M. Belslt '75 is one of
two Editors of Amyotrop hic
Lateral Sclerosis: Diagnosis and
Management for the Clinician,
published by Fu tura Publishing.
408 pages, 43 illus tra tions, $90.
ALS is also known as Lou
Gehrig's disease or motor
neuron disease. Dr. Belsh is an
Associate Professor of Clinical
eurology and Director of
the Neuromusc ular and ALS
Cente r at UMDNj-Robert
Wood j ohnson Medi cal School.
Changes in Care
Barry C. DOni '6 7 is co-
au thor of Renegotia ting Health
Care, published by jossey-Bass
of San Francisco. The book
grew out of Dr. Dorn's teach ing
as Associate Director of th e
Program on Health Care
Nego tia tion at th e Harvard
School of Public Health. He is
also a Clinical Professor of
Orthopaedic Surgery at Tufts
University School of Medic ine.
Varied Advice
Thomas D. Meade '83 of
Allentown, PA is th e au thor of
The Medical Advisor, publish ed
by lCS Books, Merrillville , IN.
It is a co llec tio n of advice
about medicine co llec ted by
Dr. Meade since beginning
medical school in 1979.
Co ntr ibutors incl ude jefferso n
alumni an d faculty members.
New Clinical Text
Alvin F. Goldfarb, M.D .,
Professor of Obs te trics and
Gynecology at jefferson , has
edited Clinical Problems in
Pediatric and Adolescent
Gy nccology. Various contrib-
utors, 118 pages, illu st rated .
Publish ed by Cha pma n and
Hall , New York .
Manage Diabetes
Martin M. Mandel '4 7 of Blue
Bell , PA has just publish ed
Diabetes: Don't Fear It , Beat It!
My StOlY, My Mcssagc, My
Mission. Dr . Mandel has a
neu rol ogy practice based at
Holy Red eem er Medi cal
Center in Meadowbrook, PA.
High Excitement
E. Mars'Jall Goldberg, M.D. ,
Professor of Medi cine at
jefferson , ha s three works of
fict ion ava ilab le at th e
Tho mas j efferson University
Book st ore (for con tac t
informa tion , see page 38 of
th is magazine ). They are th e
medical th rill ers A Deadly
Operation ($ 14 .95 paperback ) ,
Intelligcncc ($ 14.95
paperback ) , and The Family
Scalpel ($ 25.00 cloth , $13.95
paperback ) . Published by
Dufour Editions.
Alaskan Frontier
C. Ea rl A lbred lt '32 is the
subject of Frolltier Physician
by Nancy j ordan , publish ed
by Epicen ter Press (Box
82368, Kenmore, WA 98 02 8) .
Alaska's first fu ll-time
Commiss ione r of Health,
Albrec h t was credi ted with
revolution izing health care in
th at sta te. In 1963 he became
a member of j efferson 's
faculty as a Professor of
Preventive Medicine.
An Admi red Life
Carl S. Lytle '32 of Ocala, FL
is the subjec t of The Etema!
Optimist, writte n by Peg
Masino , R. . and publish ed
by Lifestyles Press . Its account
of Dr. Lytl e's experiences as a
gene ral pr actit ion er includes a
cha p ter on his medi cal school
years at jefferson.
Thomas j effersonUniversity Hospital has
estab lish ed an In flammato ry
Bowel Disease Center. Th e
center 's main fun cti on is th e
diagn osis and tr eatment of
pati ents with inflammato ry
bowel disease (Cro hn's
dis ease, ulcerative co litis ,
co llagenous colitis , and
microscopi c co litis .) Patien ts
with uncomplicated disease
will continue to be treat ed by
their ph ysicians. Referrals are
accepted for such pati ents
from th eir ph ysicians.
The center is staffed by expert
members of th e Division of
Gastro enterology and
Hepatology an d by gene ral
and co lorec tal surgeons with
specia l int erest and skills in
dealing with inflammatory
bowel diseases. Exp ert s from
radiology, pathology, and
othe r spec ialties provid e
addition al consultation.
Outstanding facilities offer
up -to-date and evolving
modalities for on e- tim e
evalua tion, second opinions,
or long-term treatmen t.
"Inflammato ry bowel disease
ra nges from mild to severe to
life-threatening," says Franz
Go lds tein '53, Professor of
Medi cine and ac ting director
of the center. "There are one
to two milli on people in the
United States wh o suffer from
bowel disease. This is a
disease which requires muc h
atte nt ion ."
Dr. Go lds tein has been
affiliated wi th Jefferson for the
last 40 yea rs. He was awarded
a mastersh ip fro m the
Ame rican Co llege of
Gastroe nte ro logy and has
autho red more than 130
ma nuscripts , man y on inflam-
matory bowel disease. Dr.
Go lds tein was nominated by
co lleag ues as one of the "best
doctor s in the ortheast" for
inflammatory bowel disease.
The cen ter is loca ted on the
fourth floor of Main
Building.
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S T A F F EARN MA J 0 R AWARDS
Receiving the award from lordan ,. Cohen. M.D .. AAMC President
(right) are (at center) Mary B. Mont eith . Executive D irector of the
Alumni Association . and (left) Malcolm Clendenin. Associate Editor
and Designer of the Bulletin.
125th Anniversary Celebration Wins
National Award from Associat ion of
American Medical Colleges
)oftn L. Abruzzo, M. D. ,
Professor of Medicine, has
been elec ted th e first Presid ent
of the Easte rn Pennsylvan ia
Osteoporosis Soc iety.
Salman Aklttar, M.D.,
Pro fessor of Psychi at ry , has
received three honors: Best
Pap er of th e Year Award from
th e Journal of the America n
Psychoanalyti c Associa tion for
his pap er , "A Third
Indi viduation: Immigration,
Identity, and th e
Psychoan alyt ic Pro cess "; th e
Mahler Literature Priz e from
th e Mahl er Psychiatric
Research Foundati on for th e
same pap er ; and th e
Hasenbush Mem orial Visiting
Professorship at Harvard
Medical Schoo\.
Paul C. Brucker, M.D.,
President of Th omas j efferson
Universi ty , has been elec ted
by Grea ter Philad elphia Firs t
to its Board of Directors. GPF
is an association of bu siness
chief execu tives formed in
1983 with th e mission of
advan cin g eco no mic growth
and th e quality of life in the
Delaware Valley.
Carlo M. Croce, M.D.,
Chairman of Microbiology
and Immunology and Director
of th e Kimmel Cancer Center ,
has been elec ted to th e
Natio na l Acade my of Sciences
in recogni tio n of his ac hieve-
men ts in resear ch .
Larry A. DorIOSO, M.D.,
PII.D., th e Duan e Pro fessor of
Oph tha lmo logy a t j efferson
and W ills Eye Hosp ital , has
been honored by th e crea tion
of th e Lar ry Donoso Eye
Research Laboratory at
Qu eens Medi cal Center ,
No tt ing ham Uni versity, in
England.
Robert D. Fry, M.D.,
Th e Marks Professor and
Director of Co lorec tal
Surgery, has been
appointed to th e Executive
Co unc il of th e Am eri can
Soc iety of Co lon and Rectal
Su rgeons.
Alvin F. Goldf arb, M.D. ,
Professor of Ob st etrics and
Gynecology, presented the
Sir john Dewhurst Lecture,
entitled "Adolescen t Sexual
Behavior: Its Impact on
Future Reproduction," at
th e 20th annual meeting
of th e North American
Society for Pediatric and
Ado lesce n t Gynecology.
Gerald). Herbison, M.D.,
Professor and Dir ector of
Resear ch in Rehabilitation
Medi cine, was honored by
th e Ame rican Acade my of
Ph ysical Medi cin e and
Rehabilitat ion as one of
its 1996 Dist in guish ed
Clin icia n Award recipients.
TllOfJlas B. Knudsen, PII.D.,
Asso ciate Professor of
Pathology, Anatomy, and
Cell Biology, has been
invited to serve as a charter
member of th e Human
Embryology and
Development (2) Study
Section of th e National
Institutes of Health.
Dennis B. Leeper, PIt.D.,
Professor of Radiation
Oncology and Director of
Radi obi ology, is President-
Elec t and Cha irma n of
th e Pro gram Co mmittee
of th e No rt h American
Hyp erthermia Society. This
society su ppo rts research in
th e mechanisms and us e of
hyp erthermia in th e
treatment of cancer.
Mark Scllwei tzer, M.D. ,
Associate Professor of
Radi ology, has wo n th e
Scho lar Awa rd of th e
Radi ological Society of orth
Ame rica , an award presented
to only four radi ologist s
per year.
The 125th AnniversaryCelebration for th e
jefferson Medi cal Co llege
Alumni Association has wo n
a nati onal prize from th e
Associa tio n of Ame rica n
Medical Colleges. The AAMCs
Awa rd for Excelle nce in
Public Affairs was presented to
j efferson for thi s multifaceted
celebration of th e history and
future of th e medi cal co llege.
It included four issues o f th e
Bulletin cu lm inating in th e
special Spring 1995 issu e,
Troy L. Thompson II , M.D. ,
The Lieberman Professor and
Chairman of Psychiat ry , has
been elected to a three-year
te rm on the national Board
of Direc tors of Alpha Omega
Alpha Honor Medi cal
Society.
a video , a Mayor's procla-
mat ion, an d enhanced eve nts
during 1995 with a special
sc ientific symposium and ga la
Reunion Weekend . The
project's success was a co llab-
oration of the lead ership of
th e Alumni Association and
th e professional talents of the
j efferson Medical College
Alu m ni Office . Among th e
judges' co m ments: "Much to
celebra te and you did it so
we ll." "The ma gazine could
not hav e been better."
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EVENTS RECOGNIZE DIS LJUISHE)
a longtime suppo rter of
medi ca l interest s ,
The President's Club Din ner
was held at th e Ritz-Carlt on
and adjoin ing Rot unda at
Liberty Place , th e smart
Ce nte r City co mplex of glass ,
blue metal , and gra nite
design ed by Helrnut j ah n.
Receiving special recogn ition
at th e dinner were 16 new
members o f th e Winged Ox
Soc iety and four new Fellows
of th e Presiden t's Club,
The recepti on in the Rotunda
Sidney Kimmel Receives Cornerstone
Award at President's Club Dinner
Sidney Kimmel washonored wit h the
Cornerstone Award at the
Presiden t's Club Dinner on
October 4 ,
In appreciation of a gift of
$ 10 million from the Sidney
Kimmel Fo undation ,
Jeffer so n's cancer center was
nam ed the Kimmel Cancer
Center ea rlier thi s year (see
the Ju ne Bulletin) , Mr. Kimmel
is fou nder and chairman of
the J ones Apparel Group and
(At left) L. Roy
Newman '49 and
Leon L. Berns '3D
At the Dinner for
Class Agents and
Reunion ChainnCJ1
on September 30 are
(above) lohn T.
Comber '9 1. Una P,
Sinha '91. and
Benjamin Bacharach
'56, Chair man of the
Presid ent 's Club .
Eugene F, Bonacci '56
and Sharon B, Mass '93
at the Class Age nts
Dinne r Sep tember 30
lohn R, Prehatny '57
with Herb ert G.
Hopwood lr. '58
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Dean and Senior Vice
President lor Academic
Affairs loseph S.
Gonnell a. M.D . and
K<lY Huebner. Ph.D ..
Professor or
Microbi ology and
Immunology
Emanuel Rubin. M.D ..
the Apo nte Pro fessor
and Chairman or
Patho logy. A natomy .
and Cell Biology.
and Robert L. Brent.
M.D .. Ph.D ..
the D istinguished
Professor and past
Chairman or Pediatrics
Sidney Kimmel with
David L. Paskln '64
and Richard H.
Rothman ORS '68
Herbert E.
Cohn '55:
Francis E.
Rosato. M.D .
(the Gro ss
Professor
and
Chairman
or Surgery):
and Melvin
L. Moses '62
University President Paul C. Brucker. M.D.: Sidney Kimmel
(hold ing the miniature statue or Thomas lefferson which was
presented to him) : Rena Rowan: Carlo M. Croce. M.D ..
Director or the Kimmel Cancer Center or Thomas leflerson
University: and Ioseph S. Gonnel la. M.D.. Dean and
Senior Vice President for Academic Affairs
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OBITUARIES
Corrcction: Th e obituary in the
j un e 1996 Bullc/in of Benjamin
Provisor '32 did not sta te that he
is survived by his wife, Len or e,
of Passaic, J, and two
daugh ters. Dr. Prov isor had
prac ticed in Passaic, after havin g
take n his postgradu ate train ing
in surgery at the Unive rsity of
Pen nsylvan ia. Dr. Provisor 's
gra ndso n, Eric P. Kleinbaum, is
cur rently a firs t-yea r stude nt at
jefferso n Medical Co llege .
Louis F. Burkley Jr. '20 died
june 16, 1996 at age 99 years. He
practiced obste trics in Easton,
PA and se rved on the obstetrical
staff of Easton Hospital, Easton ,
PA. He co- founded the hospital's
prenatal clini c and tau ght
obstetrics at the hospital's
nursing schoo l for 35 years. He
earned the nic kna me "Papa"
Burk ley beca use of his compas-
sio na te devo tio n to pati ents . He
is survived by a da ugh ter.
Verne S. Cavi ness '2 1 die d
August 22, 1996 at age 101
years . He ope ned the first
in tern al medici ne practice with a
specia l inte res t in card iovascu lar
d iseases in Raleigh , NC in 1923.
He served as Chie f of Gene ral
Medicine at SI. Agnes Hospit al
and Chief of Cardiovasc ular
Medi cin e at Rex Hosp ital ,
Raleigh , NC, and was a Fellow of
the American College of
Physician s. He did pion eering
resea rch with insulin and on
hypert ension and was listed in
American Men oj Scicncc. He was
an Associa te Professor of Clini cal
Medicine at the Universi ty of
orth Carolina Schoo l of
Medici ne, Cha pel Hill , NC. In
1985 he estab lished the Dr.
Verne S. Cavi ness Professorship
of Investigat ive Medicine at that
medical schoo l. In 1991 the
school's Clinica l Research Uni t
was renamed and dedicated the
Verne S. Cavi ness General
Clinical Research Center. He is
survive d by a so n and two
da ughters.
Bm cc A. Grove '26 died
February 10, 1996 at age 95
years. He practiced in York, PA.
He served as Head of th e
Department of Ophtha lmo logy at
York Hosp ital , York, PA for 25
years . He was a Fellow of the
American College of Surgeons
and th e Ame rican Acade my of
Ophtha lmo logy and a past
Presid ent of the York County
Medi cal Socie ty. He is survived
by two sons .
Reginald A. Allen '32 died
Augus t 3, 1996 . He pra ctic ed
pediatrics in Providence, RI for
53 years, retiring in 1988. He
was a member of the New
England Pediatric Society and a
Fellow of the American Acad emy
of Pediatrics. He is su rvived by
his wife, Anne tte, two so ns and
two dau ghters .
George A. Baver '32 died April 8,
1996. He lived in Pennsburg, PA
and had pra cticed famil y
medi cin e. He is survived by his
wife.
John Bower '33 died October 14,
1996. A member of Alph a
Omega Alpha Hon orary
Fratern ity, he practiced
psychi at ry in Reading, PA. He
was Director of the Department
of Psychi at ry and Neuro logy at
Reading Hospital and a Staff
Psychiatrist at SI. joseph's
Hospi tal, Reading. PA. He is
survived by three sons. Son j ohn
is jefferson '66 and son Edward
is j efferson '70.
Gilb ert M. Halpern '34 died july
15, 1996. He pra ctic ed gene ral
and occ upa tiona l medi cin e in
Hon olulu, HI and was on staff at
Quee ns Hospital in Hon olulu .
He was Med ical Director of the
Dole Compa ny, Hon olulu, HI for
35 years. He is survived by
seve ral chil dre n.
Benjamin P. Houscr '34 died
May 18 , 1996. He pract iced as an
eye, ear, nose and throat
specia list in Tamaqua, PA. He
was on staff at the former
Coalda le State General Hospital ,
Coaldale, PA, Gnaden Huett en
Memorial Hospital, Lehighton ,
PA and Pottsville Hosp ital,
Pot tsville, PA. He is survived by
his wife, Ruth , a son and two
daughters .
Dennot Lohr '34 died june 28,
1996. He practiced public health
in Lexington , C. He was
associa ted with the Smith-Lohr
Clinic and Lexington Memo rial
Hosp ital , Lexin gton , NC. He is
surv ived by his wife, Blanc he ,
and two sons.
Jo scp/J F. Hugh cs '35 died
September I, 1996 . A board-
cert ified Gen era l Surgeon and
Fellow of the Ame rican Co llege
of Surgeons , he was Chief of
Surgery at Wilmington Medi cal
Center and SI. Fran cis Hospital ,
Wilmington, DE. After retiring
in 1979, he moved to Hon olulu ,
HI and worked as Med ical
Officer, disability evaluat ion,
Vetera ns Adminis tra tion
Region al Office, Hon olulu, HI.
He is survived by his wife , Mary ,
two sons , and a daug hter.
Franll M. Grem '40 died july 21 ,
1996. A board -cert ified
Anesthesiologist, he prac ticed at
Oak Park Hospital , Oak Park, IL.
He held appointme nts as
Assistant Professor of
Anes thes iology, University of
Illinois School of Medicine and
Professor of Anesthes iology ,
Loyola University Schoo l of
Dentistry. He se rved as
President, Chicago Socie ty of
Anes thes iologists in 1950 and
Presid ent , Illinois Socie ty of
Anes thes iologists in 1959. He is
surv ived by three daughters and
a so n. Son Philip is j efferson '76
and daughter jean is jefferson
'80.
Dale T. Anstine '42 died October
15,1 996. He was an internist
wi th a subspecia lty of cardiology
and practiced in Hollywood , FL.
He was a past Chief of Staff at
Doctors' Hosp ital of Hollywood,
and a Fellow of the American
Co llege of Cardio logy. He is
surv ived by his wife, Mabel, two
sons , and two daughters.
Riellard D. BausclJ '42 died july
19, 1996. He pra cticed in
Allentown, PA and was a Fellow
of the Ameri can Acad emy of
Family Physicians . He was on
staff at Sacred Heart Hosp ital ,
Allentown, PA. He is survive d by
his wife , Emma, four sons, two
da ughters, a stepson , and a
stepdaughter.
JO/III W. Galson '42 died Augus t
9, 1996. He practiced int ernal
medi cin e in Philadelphia, PA and
was on sta ff at Presbyterian
Hospit al, Philadelphia , PA. He is
survived by his wife, Margaret, a
son, and two daught ers.
Stephen ] . Mm1/JOusc '42 died
Sep tember 6, 1996. He
maintained a gen era l practic e in
Lewistown, PA for 35 years. He
is survived by his wife, Harri ett e,
three sons, and two daughters.
Sta nley N . C1arll S'44 died
May 9, 1996 in Provo, UT, it has
bee n ascertained .
David A. Culp S'44 died October
7, 1996 . A board-certified
urologist, he was Professor and
Chairman of the Department of
Uro logy , University of Iowa
College of Medicine , Iowa City.
He contri buted man y articles to
the urologic litera ture and co-
au tho red th ree books. A Fellow
of the America n Urologic
Associa tion, he later served as
Presid en t of the organization. He
is survived by his wife, Anna ,
three sons and two daughters.
StCf'/ICJI Soro/lanielJ S'44 died
Apri l 27 , 1996. He was a General
Prac tit ioner in Old Forge, PA. He
is survived by his wife and son,
Stephcn jr., who is j efferson '8 1.
Dram R. KlineJr. '45 died
September II , 1996 . A board -
certified Ophthalmologist . he
held staff appointments at
Coo per Hospi tal , Camden , Nj ,
Underwood Hospital ,
Woodbury, Nj , and Wills Eye
Hospit al , Philadelphia, PA. He
held a j efferson faculty
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appointment as Clinical
Professor of Ophthalmology and
served as President, ew Jersey
Ophthalmologic Society in 1970.
He is survived by his wife , Sue
Ann , a son, and a daughter.
Rocco P. Sciubba j r. '45 died
Augu st 1, 1996 . He was in
general practice in Broomall, PA
and held a staff appointment at
Haverford-Mercy Hospital,
Ardmore, PA. He is survived by
his wife , Jeanne, two sons and
two daughters.
1. Ralpl. BlIJvridge]r. '46 died
August 19, 1996 . Certified by the
American Board of Psychiatry
and eurology, he practiced in
Eric, PA. He held a staff
appointment at Hamot Medical
Center , Erie , PA and a teaching
appointment at Western
Psychiatric Institute , Pittsburgh ,
PA. He is survived by his wife,
Olga , four daughters, and son
Geoffrey, Jefferson '77 .
Edwin M. Mszanowslli '4 7 died
August 14, 1996 . A General
Surgeon, he pra cticed in Erie ,
PA. He was a full time member
of the active surgical staff at
Hamot Medical Center, Erie , PA.
He is survived by his wife , Millie ,
two sons, and three daughters .
C1larles R. Bal1on]r. '48 died
November 3, 1996 . He was in
general practice in Glenolden,
PA and served as borough Health
Officer. He relocated to
Scottsville, VA in 1970 and
practiced as a Country Doctor
until retirement in 1981. He is
survived by his wife , Marjorie ,
and four sons.
C1larles G. Steinmetz HI '48
died September 16, 1996. A
board-certified ophthalmologist ,
he was on staff at Bryn Mawr
Hospital , Bryn Mawr, PA and
Wills Eye Hospital , Philadelphia,
PA where he had served as Chief
of the General Ophthalmologic
Servic e. He was a Clinical
Associate Professor of
Ophthalmology, Jefferson
Medical College. He is survived
by his wife, Megan, a son , a
daughter, and two stepdaughters.
Roben L. Eva ns '52 died October
22, 1996. A board-certified
internist, he had a distinguished
career in medical education,
including teaching appointments
at jefferson Medical College and
the University of Maryland. He
was the first Director of Medical
Education at York Hospital , York ,
PA and , in 1995, the Education
Building at York Hospital was
named in his honor. He later
served as the founding Dean of
the University of lIlinois School
of Medicine, Rockford, IL, and as
President of the Cooper Medical
Center, Camden, J. A member
of numerous medical and
educational organizations, he was
President of the Association for
Hospital Medical Education . He
served as an Alumni Trustee on
the Board of Trustees of Thomas
Jefferson University, 1971-1977.
He is survived by his wife , Peggy,
and two sons.
Louis]. Wagner '52 died
September 28, 1996 . A board-
certified general and thoracic
surgeon, he practiced in Oil City ,
PA. He was on staff at the
Franklin Regional Medical Center,
Franklin , PA. He is survived by
his wife , Mary , and a daughter.
Robel1 N . Cottone '56 died July
21, 1996. A board-certified
Urologist , he practiced in
Trenton , J. He was on staff at St.
Francis Medical Center, Trenton,
J where he was Chief of Urology
and a former President of the
Medical Staff. He is survived by
his wife, Jackie, five sons, and
two daughters.
Howard S. Silven na n '83 died
August 21 , 1996. A noted
researcher and clinician, he was
an IH-funded cellular ph ysiol-
ogist and an Assistant Professor
of Medicine, Johns Hopkins
University School of Medicine ,
Baltimore, MD. He is survived
by his wife , Roseanne, and
two sons.
Harold L. Israel '34
A noted pulmonary diseaseresearcher and clinician and
an Emeritus Professor of
Medicine at Jefferson , Harold L.
Israel '34 died November 22,
1996 . His major clinical interest
was sarcoidosis and his work on
this disease received int erna-
tional recognition. He had been a
member of the International
Committee on Sarcoidosis since
1958 and was Vice President
of the 10th International
Co nference on Sarcoidosis
Gustave Edward Zerne OTO '53
died July 12, 1996 . He received
his postgraduate education in
otolaryngology at jefferson and
practiced in Lebanon, PA.
] . Leonard Ivins P'66 died
October 20, 1996. He completed
a psychiatry residency at
Jefferson . He was on staff at
Haverford State and Haverford-
Merc y Hospitals, Haverford , PA,
and Belmont Hospital and the
Institute of Pennsylvania
Hospital , Philadelphia, PA. He is
survived by a son and two
daughters.
Margaret Riley Scim eca P'78
completed a psychiatric
residency at Jefferson . She died
on an unknown date in 1996 , it
has been ascertained . She is
survived by her ph ysician
husband .
]ole C. McCurdy P'81 completed
a psychiatric residency at
Jefferson. He died on an
unknown date in 1991, it has
been ascertained .
SuzarUle M. W ester OBG'88
completed a residency in
obstetrics-gynecology at
Jefferson . She died January 9 ,
1996 , it has been ascertained.
in 1984 . A f~miliar figure on the
Jefferson campus , Dr. Israel
held man )' imp ort ant posi tions
during his caree r incl udin g
Assistant Director, Tub ercul osis
Division , Philadelphia
Department of Health ; Assista n t
Visiting Physician and Visiti ng
Physician , Phil adelphia General
Hospital ; Pulmonary
Co nsulta nt, Valley Forge Army
Hospital , Philadel phia aval
Hospital , and Wilmington
Veteran s Administra tion
Hospital ; Member , Natio nal
Heart and Lun g Institute Tas k
Force on Research Approaches
to Respiratory Diseases; and ,
since 1976, an Hon orary
Member, British Thoracic
Society,
Following a two-year internship
at Philadelphia Ge neral
Hospital , he pursu ed his
int erest in pulmon ary diseases
at th e Henry Phipps Institute,
University of Pennsylvani a and
earned an M.P.H. degree from
the University of Pennsylvani a
in 1942 . He spent three years in
the U.S Army Med ical Corps
during World War II, attaining
the rank of major. Following
teaching appoi nt me nts at the
University of Pennsylvan ia,
Wom an 's Medi cal Co llege and
th e Graduate Schoo l of
Medicine, Univ ersit y of
Pennsylvania, he returned to
Jefferson in 1959 as Clinical
Professor of Medicin e. He was
mad e Professor of Medicine in
1972 . On his ret irem ent in
1982 , he was mad e Emeri tus
Professor and was awa rded the
Dean 's Medal in recogn ition of
his many co ntr ibu tions to
medical education, clin ical care,
and innovative research . Over
his career Dr. Israel publish ed
201 scient ific articles. He is
survived b)' two so ns , two
daughters, and two stepsons.
Son Dani el is Jefferson '67.
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Gartland Elected Alumni Trustee
Please submit news for Class Not es to:
Attention: Alulllni Bulletin
j efferso n Medical College of Th omas jefferson Un iversi ty
10 20 Locust Street, Su ite M-4 I
Philadelphia, PA 19107-6799
Would you lille to contact the Alulllni Offi ce electronically?
If so, yo u can se nd yo ur name, cla ss yea r/specialty, and
in formation suc h as address changes or per sonal and
professiona l cha nges to : jmca/ums@jeflin.tju.edu. T he
e-mail address of the Bulletin is : ied/72w@tjuvm.tju.edu.
Readers are encouraged to submit '1OIIIi"ations fo r:
1) Alulllni Trustee of Thomas jeffel"Son Univers ity: One is
elected eac h year for a th ree -year term (he or she may be
reelect ed for one additiona l term) . Please submit names of
worthy ca nd idates to "Atte n tion: Alumni Trust ee Committee ,"
1020 Loc us t Street , Su ite M-4 I , Philadelphia , PA 191 07.
2) AluJlJni Ad,ieveJlJent Award: Alth ough th e award carries
no monetary stipe nd, eac h recipient's name is perman entl y
affixed to a p laq ue promin ently displayed at th e entrance to
jefferson Alum ni Hall. The recipi ent is pr esented with a
han dsome silve r tra y, suitably eng ra ved and bearing th e sea l
of th e medical college, as the highlight of th e Alu m ni Banq uet
each j une. The Achievemen t Awa rd Co m mi ttee of th e Alumni
Association is charge d with the fina l selectio n; th e committee's
d ecisions ar e no t su bject to review . Please direct curricu la
vi tae and bibliographies of alu m n i w hose professiona l
ac tivities are su fficien tly outstanding to wa rra n t co nsideration
to "Atte n tion : Achieve me n t Award Co m mittee, "
102 0 Locust Stree t, Suite M-4 I , Philadelphia, PA 19 107.
'47 50th Reunion lune 6-8
co m ple ting his second
ge nerous U.S. Scientist Award
from the Alexander von
Humboldt Foundation . As a
res u lt o f his collaboration
wi th Pro fesso r Siegfried
Me nse at the University or
Heidelberg , Dr. Simons
submi tted a paper with
Professor Meuse that received
a co m pe ti tive award from th e
Stra th mann company, th e
Forderpreis Muskelrelaxation
(com pe ti tive award fo r the
best paper o n the subject of
muscle relaxation) .
Jam es T. Helsper or Pasadena,
CA has been appointed
Professor of Clinical Surgery
'46
'32 65th Reunion lunc 6· 8
David G. Simons of
Huntington Beach, CA is
Nathan S. Sd llezinger o f
W yn cot e, PA was on s tage at
the Acade my o r Mu s ic at
Co m me nce me n t las t june
when his gra ndso n, j effr ey A.
Simon, M.D., grad ua ted in th e
Class of '96. Dr. Sch lez inger is
an Eme ritus Professor of
Ne uro logy .
'42 55th Reunion lune 6-8
J. Arthur Steitz of Medford,
Nj has retir ed and is
"e njoying being in a
retiremen t community."
College, Dr. Ga rt land head ed
the department from 1970 to
1985. He is th e au tho r of
Fundamcnuiis of Orthopaedics,
a pa st President of the
Ame rica n Acade my of
O rt hopaed ic Surgeons, and
a fonner Assoc iate Ed ito r of
th e [ourn a! of Bone and.Joint
Surgery.
Dr. Mill er has taught an ato my
a t j efferson for more than 40
yea rs as a fu ll Professor and
curre n tly is an Honorary
Assoc iate Professor in th e
surgical d ep artment. He
received an honorar y degree
of Doctor of Science from
Villa no va Unive rs ity in 198 2.
Th ree of hi s five child re n , as
well as his so n-in- law, are
jeffer son grad ua tes.
In addition to thi s importa nt
wo rk, Dr. Mi ller has carried
ou t research on th e further
design and devel opment of
heart- lung machines ; and th e
use of ex traco rpo real circ uits
for th e treatment of malign ant
tumors of th e ex tre mities with
high -d ose cancericida l age nts ,
w hil e the ci rc u latio n of th e
ex tre mity is iso lat ed during
tr eatmen t by an ex tracor-
porea l circ uit and th e esc ape
of drug to th e ge ne ra l
circ u la tion is minimi zed .
Dr. Mill er was the research
associa te of j ohn H. Gibbo n
jr. '27 from 1950 to 1953 ,
and th rough his co lla bo-
rati on, th e heart -lu ng
mach in e developed th e
necessary co nt ro ls and Iluid
mechanics and feedback
co ntrol sys te ms to ena ble the
first successfu l ope n- heart
ope ra tion in th e wo rld .
Miller Receives
ASME's
Holley Medal
Bern ard J. Mill er '43received th e prest igious
Holl ey Medal on Novembe r
20 at th e an nual int erna-
tional meeting of th e
Ame rica n Soc ie ty o f
Mech an ical Eng ineers
(ASME) in Atlan ta. Th is
award was es ta blis he d in
192 4 to honor Alexande r
Lym an Holl ey. It wa s give n
this yea r to Dr. Miller for th e
innovative applicatio n of
fluid mech anics in the
design of a feedback co ntro l
sys te m ena bling th e hea rt -
lung machine to ass ist wi th
an ope n-heart ope ra tio n
performed for the firs t time
on a human bein g in May
1953 .
ohn J. Ga rt land S'44 was
elec ted an Alu m n i Trust ee
th is yea r th rough th e ball o t
th at was mail ed to eac h
j efferson grad uate, including
post graduat e alu m ni .
The j am es Edwa rds Professor
Eme ritus of O rt ho paed ic
Surgery at j efferson Med ical
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(fu ll- time faculty) a t th e
Unive rsi ty of So u the rn
Ca liforn ia School of Medi cine
in Los Ang eles .
'48
Eugene P. Htlg/,es of
Plym outh Meeting, PA has
re tire d and is doing much
go lfing , hunting , and fishing.
His wi fe, j an e, has accepted a
position as President of
Whitemarsh Valley Cou nt ry
Club.
'49
Th e Albe rt Eins tein Soc ie ty
honored L. Roy Newman o f
Elkins Park, PA at its annual
d inner on Sep tem be r 25,
1996. Dr. ew rnan was
recognized for his se rvice to
Albe rt Eins te in Medi cal
Ce nte r and the Eins te in
Soc iety that su pports medical
research and innovative
pati ent ca re .
'52
Jam es E. Clarl: of
Swa rt h more , PA was honored
in ove rn bc r by Crozer-
Cheste r Medi cal Ce nt er. The
occasion wa s th e National
Philanthropy Day lunch eon
orga nized by th e Gr eat er
Philadelphia Cha pte r o f th e
atio na l Soc ie ty of Fu nd
Raising Execu tives. Dr. Clark
cha ired Crozet-C hes ter's
Medi cal and Dental Sta ff
Capital Cam pa ign, which
raised ove r $2 .1 million for an
Education Ce n te r and
Ambulatory Care Pavilion .
Th e ce nte r is nam ed in hi s
honor. Dr. Clark is Chairma n
of th e Department of
Medi cine and Dir ector of
Med ical Ed uca tio n at Croze r-
Cheste r, and a member o f th e
Board of Dir ectors o f th e
Crozet -Keys to ne Health
Sys tems. In pa st yea rs at th e
atio na l Phil anthropy Day
lunch eon ,J. Wallace Davis '42
and Be'yamin Bacha rach '56
have been honored by
jefferson Medical Co llege.
'54
Robert A. Hin richs of Co ro na
Del Mar, CA has limited hi s
practi ce to two to three days a
week, "so now my golf is
better. "
'55
Jo sepl, A. Hean ey of
Cu m be rland, WI is a locum
ten ens psychiatrist spec ial-
izing in for ensic psychiatry for
th e sta te mental health
sys te m . His wife , Mary Brust
Hean ey, has publish ed a book,
Belovcd Stra ngc r: ReJlections on
Menta! Illness, drawing on
their years in psychiatry.
J . Donald Sdlllltz is happi ly
retired in Shelbu rne , VT along
with Robert W. Luhens j r.
'57 40th Reunion Iune 6-8
George A. Salverian of
Huntingd on Valley, PA ha s
recently retired , with 43 years
of devoted dedi cation
following his excellent
training at jeffer son. His wife,
llah , and famil y j oined him in
ce lebrating his retirem ent.
'58
Edwi n R. Co ncors of Ryd al ,
PA is s till active in practi ce.
Jo/m K. Kreider of Manheim ,
PA is enjoying taking care of
pri soner s at Dauphin Cou n ty
and Berks Cou nty State
Hospitals , and is enjoying his
five wo nde rfu l gra ndc hild re n .
'60
W ill iam H. MallOod of
Flourtown , PA wa s elect ed an
AMA Trust ee in june 1996.
Rtldolf Bee of cw Britain , CT
is s till practi cing ge ne ra l
ophthalmology. He has three
children , ages nine to 12.
Recentl y, he received th e
high est license in amateur
radi o .
'61
A'1/nu' . Meya of Kingst on,
PA is in private practi ce of
hematology/oncol ogy in
Kingston . His wife, Barbara, is
his offic e manager.
William B. Pratt of Gallup ,
NM ha s been at th e Gallup
Indian Medical Center as an
orthopaedi c surgeon since
1987. His plan is to reti re in
"abou t tw o years ."
'63
Jo/m N. Rig/,tmyer of
Hamburg, PA has retired from
his family practice and from
his work at Wernersvill e State
Hospital. Dr. Rightmyer will
be th e District Governor for
District 7430 Rot ary
Int ernati onal from july 1997
through 1998.
'66
Franklyn R. Cool: of
Carmichael , PA is feeling
excelle n t despite a past
pn eumonect omy for lung
cance r.
Mid,ael P. Dolan of ew
Orlean s , LA ha s now retired
as th e Medi cal Dir ector of
Health Services of Lockheed
Martin Manned Spa ce
Syst ems. He and his famil y
plan to remain in Ne w
O rlea ns. No w th ey hav e th e
time to go sailing in th e
Ca ribbea n!
'67 30th Reunion lunc 6 8
Carl L. Stanitsl:i of Grosse
Pointe Farms , MI is now on
Bowman is Fi rst
Chair of Family
Medicine at Penn
Marjorie A. W . Bowman'76 ha s been
appointed th e first
Chairman of th e newly
created Department of
Family Pra cti ce and
Com m unity ledi cin e at
th e University of
Pennsylvania School of
Medicine. Dr. Bowman
is a past Pre sident of th e
Society of Teach ers of
Family Medicine and is
President-Elect of th e
o rt h Carolina Academy of
Family Physician (until
her appointment at Penn
she chaired th e Department
o f Family and Co m m un ity
Medicine at Bowman Gray
School of Medi cine of
Wake Forest University) .
" I've been involved for a
lon g time in growing family
medi cine at aca demic
institutions," she says.
"I'm pleased to have th e
hands-on opportunity to do
this at Penn."
Dr. Bowman is Edi to r of
the Archives oj Family
Medicine and se rves on th e
ed ito rial board of the
journal oj the American
Medical Association. She has
been elect ed to th e Institu te
of Medi cine of th e atio na l
Academy of Sciences.
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'78
Mel issa R. Spevak of
Baltimore, MD and he r
husband , Phil, are both
working at J ohns Hopkins
Hospital, she in ped iatric
radiology and he in pedi atric
card iology . They are enjoying
their children Sarah , age four,
and James, age 21 months.
Bruce E. Nayowith of
Rhinebeck , Y is working in a
small emergen cy room in th e
Ca tskills, and helping his wife
school their four chi ld ren at
home.
'77 20th Reunion lune 6-8
Dale N. Goode of Yardl ey, PA
is prac ticing emergency
medicin e in Trenton, NJ and
also enjoying occupational
medicin e at Lockheed-M artin .
He we nt to Russia and
Kazakhstan in May.
Dr. Ashley-
Gilber t
Stateme nt of Owne rship, Managem ent . and Cir cu latio n (PS Form 3526 )
(req uired by 39 U.s.c. 3685, United States Postal Service )
I . Publ icati on tit le: )rffcrsoll Mrdi w/ Co//<:gr A/ulllni Bullrlin
2. Publi cati on number : 0021 5821
3. Date of filing: 10/96
4. Issu e frequency: four per year
5. Numbe r of issues published an nua lly: four
7. Co mplete ma iling add ress of office of publication:
Suite M-4 I , 1020 Locu st Stree t, Philadelphia , PA 19107
8. Mailing address of gene ral busin ess office of publish er : same as above
9. Publisher: Jefferson Medi cal College of Th om as j efferson University (add ress above)
Editor: Mary B. Monteith (add ress above)
Managin g Edito r: Malc olm Clende nin (add ress above)
10. Owne r: Jefferson Medi cal Co llege of Th om as Jefferson Universi ty (add ress abov e)
II . Bondhold ers, mort gagees, and othe r sec uri ty hold ers owni ng or hold ing one percent
or mor e of to tal amo unt of bonds, mort gages, or othe r securities : none
12. For nonprofit orga niza tions au tho rize d to mail at specia l ra tes:
th e purpose, fun ct ion , and nonprofit sta tus of th e o rganizatio n, and the exempt status
for Federal incom e tax purposes have not changed d ur ing the pre ceding 12 months
15. Extent and nature of circulation Average umber Copies Actual , umber Copies
of Each Issue Duri ng of ingle Issue Published
Preced ing 12 Mont hs carcst to Filin g Date
A. To tal number of co pies (net press run ) 18,500 18,500
B. Paid and/or req ues ted cir culatio n
I . Sales th rou gh dealers, ca rr iers ,
street vendo rs, co unte r sa les 0
2. Paid and/o r requested mail subsc riptions 17,900
C. Total paid and/or requ est ed ci rculation 17,900
D. Free distribution by mail 290
E. Free d is tribution outside the mail 300
G. Total distribution 18 ,490
H. Copies not distributed 10
I. TOTAL 18,500
Percent paid and/or req uest ed cir culation 97%
A,m As/dey-Gilbert and
Genester Wilson King '82,
both of Alta mo nte Springs, FL,
along with Billie J ean Pace,
M.D., have formed "the first
women's group gynecology
practi ce in Seminole and Lak e
Co u nties" in Flo rida. The
Alta mo nte W omen 's Ce nter
ope ne d in Septembe r 1996.
Dr. King
'76
'74
Paul A. Bialas of Warren , PA
co n tinues in active gene ral
internal medicine practi ce in
W arren , PA. He se rves as Vice
Pres ide nt of th e Medi cal Sta ff
and is a member of th e Board
of Tr us tees at Warre n Ge ne ra l
Hosp ital. Governor Ridge has
j ust appoi nted Dr. Bialas to a
five-year term on th e Warren
Sta te (Psychiatric) Hospital to
commence in January 1997.
Leland D. Cropp er Jr. of
Oilville, VA has a privat e
practice of vascu lar and
interventiona l rad iology and
d iagn osti c rad iology. He is
now Chief of Radi ology at
Healthsouth Medical Ce nte r
in Richmond, VA.
joanna R. [ohnson of
Malvern, PA married David
J ohnson Jr. on Oc tobe r 8,
1995. Co ng ra tu la tio ns!
Richard M . Sostowski of
Livingston, NJ recently passed
th e subspecialty boards in
forensic psychia try.
W ill iam A. DiCuccio of
Butler, PA is the Medical
Directo r for Sun nyview
(Butler Co un ty's nursing
home) and Butl er Co unty
Prison .
'72 25th Reunion June 6-8
Steven A. Ager of Che rry Hill ,
J was voted by New J ersey
p hysicia ns to be one of the
psychiatris ts by whom th ey
the mse lves wo u ld most wa n t
to be tr eated , in a poll
co nduc ted by New Jersey
MOllthly and released in its
April 1996 To p Docs issue.
'73
'69
Richa rd Gross of Gran ite Bay,
CA passed th e CAQ
(Cert ifica te of Adde d
Qualifications) Boards in
lnterveru ion al Rad iology
(Vascular Radiology) in
ovember 1995.
La n )' S. Coheu of orth
Miami , FL is now the Medical
Director of W illiams Island
Medical Group. Larry and his
wife , Rona , celebra ted th eir
25th wedding an niversary on
J une 20 .
Ne il O. Thompson of
Balti mo re , MD re tu rns to
Tha ila nd in December 1996 .
'71
Chri stopher K. Ballwny of
St. Cloud , MN has become
board-certified in endo-
crinology and metabolism .
josep/J L. Seltzer of
Rosemont , PA has been
elected President of the
Societ y of Academic
An esthesia Chairs for a
two-year term.
the Editorial Board of the
[ournal of Pediatric
Orthopaedics . He was also j us t
named Chairman of the
Education Committee of the
Scoliosis Research Society ,
succeeding Peter D. Pizzutillo
'70 of Wynnewood, PA.
Mau /Jew W hite of Gig
Harbor , WA has expande d his
family medicine practi ce wi th
two new partners.
'70
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Scott M. Goldman '76 of Philadelph ia (third from left. above)
was the special hono ree November 21at the testimonial dinner
of the Main Line Division of the American Heart Association of
Southeastern Pennsylvania. He's one of the yo unges t individuals to
be honored in this way. With him in this photo are Lawrence Frame.
M.D.. President of the AHA of Southeastern Pennsylvania: Harmon
Spolan. Pres ident of leflerson Bank: and Peter Kowey . M.D.. Chief
of Cardiovascular Diseases at The Lanken au Hospital (a member of
the Iefferson Health System).
Ne il H. SJlUstennan of
Wynnewood , PA is enjoying
pharmaceutical med icin e at
SmithKline Beec ham. Dr.
Shusterman is in cha rge of
worldwide development of
cardiovascular and renal
drugs.
'79
Thomas]. MarsJwll]r. of
Arlington, TX was recent ly
appointed Director of Surgery
and Surgical Subspecia lties for
Kaiser Permanente , Southwest
Divisi on, based in Dallas .
Brian R. Ott of Barr ington , RI
was promoted to Associate
Professor in th e Department
of Clin ical Neurosciences at
Brow n Unive rsity School of
Medicine .
'80
Steph en A. Geraci of
Germantown, T is Associate
Program Director , Medicine
and Cardiology at the
University of Tennessee and
Assistant Ch ief of Medi cine at
th e Veterans Ad minis tra tio n
Medical Center in Memphis.
'82 15th Reunion lune 6-8
Christine C. Gamburg of
Berwyn, PA is in a clin ical
anes thes ia pr act ice at
Delawar e Co unty Co mmunity
Hospital. She is also th e
Directo r of Drexel Anes thes ia
Pain Clinic .
'83
lauren E. Bid:el of
Owensboro, KY has delivered
a baby boy. John Timothy
Bick el was born on July 20 .
Timmy joins Emily, who
tu rn s three in January. W hile
Dr. Bickel is enjoying her full-
tim e mother hood , she also
has a part-t im e family
pra ctice . May we say , "You go
girl !"
Timothy M. Heilmann of
W illia ms po rt, PA is an
Associate Director of th e
Williamsport Hospital Family
Pract ice Residen cy. His family
now include his wife , Susie ,
and th eir six chi ldre n, Kati e,
Beck y, Michael, Caroline ,
Elizabe th , and Andrew.
Thomas D. Meade and
CJwrles Norelli , both of
Allentown , PA, se t a Masters'
World Record in swi mming
thi s year in th e 200-meter
freestyle relay. Dr. orelli
won six individual even ts and
one second place at th e U.S.
Mas ters Swi mming Na tiona l
Champions hips in Cupert ino ,
CA. Also th is past yea r, Drs.
Mead e and orelli , who train
together , br ok e ano the r wo rld
record , in a four-man team
even t.
Dr. Meade presented his
resear ch on "Fe mo ral Nerve
Block Allowing Pred ictab le
Outpa tient ACL Surgery" at
the North Ame rican
Art h roscopy Assoc iation
meeting in Washing to n , DC.
He was also se lected as an
ort ho paedic consultant for th e
Philad elphia Eagles summer
camp at Lehi gh Universi ty.
Gaty Y. Ott of Cincinnati , O H
has acce p ted a posit ion as
Associat e Professor of
Surgery , Division of
Cardiot horacic Surgery at th e
University of Cinci nna ti
Medi cal Cent er. He also
assumes du ties as Directo r of
Thoracic Transplantation . He
wo uld love to hear from any
classma tes in the area.
A ndrew B. Sattel of
Moorestown, J recentl y
became a member of the
Ameri can Society for Surgery
of th e Hand and a Fellow of
the Ameri can Co llege of
Surgeons.
'84
Louis A. Knzal]r. of Ganado ,
AZ is s till on the ava ho
Reservation in Arizo na. He
has been appointed Medical
Dire ctor of Sage Mem orial
Hospital and promoted to
Clinical Associat e Professor of
Family Medicine at Baylor
Co llege of Medicine.
'85
Hany A. Coopen lJatl of
Voorhees , J is se rving as
Presiden t of th e Medi cal Staff
at Our Lady of Lourdes
Medical Center , Camde n, J.
He is a diagnosti c rad iologist
with Lourdes Radio logy
Assoc iates in Camden
Co unty , NJ.
Caml Boern er '76
of Boston with her
two six-month -olds
(llamas. that is):
Kismet and Mozart.
Dr. Boerner enjoys
ge tting away to her
llama farm in
Vermont.
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Your diploma is from jefferson Medi cal Co llege
of Thomas jefferson University-please refer
to your degree in this way.
Ralpll J. LaNeve of
Brentwood , T is now
practi cin g at Co lumbia
Sum mit Medi cal Cen te r in
Nas hv ille, TN. Ralph and his
wife, Caro l, have two
ch ildren , David , age seven ,
and Brynna , three. The
LaNeve family miss our Philly
checsesteaks (thoug h they can
now bu y Tastykak es).
'86
Robert L. Robles of San
Fran cisco is an Assistant
Clinica l Professor in th e
Department of Medi cin e a t
San Fra nc isco Ge ne ra l
Hospital. He practices
hem atolo gy, on colo gy, and
AIDS care .
'87 10th Reunion lunc 6-8
William E. BurallJr. of
Co lumbus, O H has been
appo inted an Ass istant
Professor of Surgery in th e
Division of Surgical Oncology
at th e Ohio State Univers ity
and Arth ur G. james Cance r
Hospital and Resear ch
Institute. He and his wife,
Susan, just had an add ition to
th e family. Alexandra Adela
was born july 15, 1996. Ryan
Step he n , th eir so n , turned
four in Oc to ber.
Caesar A. DeLeo III o f
Evans ton, IL is now Asso ciat e
Med ical Director at CIGNA
Health Ca re o f Illin ois .
J ohn F. and Deanna Wilso n
are proud to announce th e
birth o f th eir daughter ,
Elizabe th Kirb y Shaw Wil son ,
bo rn j uly 22 . Eliza be th joins
brothers j ohn , age II , Ritchi e ,
Ia , and siste rs Ca ro line,
seven, and Alexand ra, live.
'88
Gregory E.' Hennan of West
Point , NY is in charge o f th e
primary ca re clinic a t Keller
Army Hospital. He's been a
family doctor now for th e past
eight years and plans on
"hang ing it u p in two years or
so ." Meg, his wife, works part-
tim e in an early interv ention
program visiting ch ild ren with
possibl e developmental
delays. The Hermans have
four ch ild ren: Kati e , wh o is
six; Sara, four; Erin , two; and
Ada m, eig h t months. Th e
famil y hope to move back to
Philadelp hia soon.
Jean M. Ne lson of Pfafftown ,
C has been promot ed to
Assistan t Professor of
An esthesia at Bowman Gray
School of Medi cin e in
Winst on -Salem , C. She had
been an Instructor in
Anes thesia since 1992.
Jolm T. Rich Jr. of Clarks
Summ it, PA ha s joined an
ort hopaedic practi ce in
Scranton , PA afte r finishing a
hand surgery fellowship at
Alleg he ny Gene ral Hospital in
Pittsburgh.
Craig G. Riclnnan of Erie , PA
and his wife, Linda, are th e
proud pa rents o f Stefa nie , age
th ree, and Eric , two. Craig is
Presid ent o f the Erie Co unty
Medi cal Soc iety and President
of a Ia -phys ician group,
Presque Isle Psychi atric
Assoc iates.
Suzanne T. Sundlleim of
Boulder , CO is th e proud
mother of Co le Sco tt Voe lle r
Sund he im, born Oc tobe r Ia.
Suzanne is also Co- Direc tor o f
Cons ulta tive Mental Health
Services to Person s wi th
Developmental Disabilit ies , in
Program s for Public
Psychiatry, and Ass istan t
Professor of Psychi at ry at th e
Univers ity o f Co lorado .
Kevin M. Zallrzewslli of
Horsham, PA has received an
appointment as Vice President
of Medi cal Affairs at Graduate
Hospital in Philadelphia.
'89
N icl: Maravich ]r. o f Isle of
Palm s, SC proudly an no unces
th e birth o f his second
daughter , Brianna Brook e,
born j u ly 24. Nick also has
been appo in ted Head of th e
Radi ology Department at th e
aval Hospital in Cha rleston ,
Sc. He has co m pleted a novel ,
Fingers Uncrossed, whi ch is
awaiting publicati on .
Pllilip S. Sclnvartz of Land-
stuh l, Ge rma ny has co mpleted
his fellow ship in rh euma-
to logy and sta rte d a two -year
tour as a rh eumatol ogist.
Andrew P. Sirotnak of Den ver,
CO has been appo inted
Director of th e Child
Advocacy and Protecti on
Team at th e Child ren's
Hosp ital in Den ver. He is also
Assistant Pro fessor o f
Pedi atri cs at th e Universi ty of
Colorado School of Medi cin e.
He is acti ve in th e Den ver
Cha pte r of th e American
Acade my of Pedi atrics , and is
a board member o f th e
Co lorado Professional Soc iety
on th e Abu se of Chi ld ren
(CO PSAC) . He is a founding
member o f th e newl y form ed
Den ver Co un ty Chi ld Fata lity
Review Committee.
ClJarles D. Tullius of
Sava n nah, GA is now
practi cin g obs te tric an esthesia
at Cha nd ler Hospit al. He is
pleased to note that Kyrin
Dunston '92 and Rcbccca
Hogue '90 are also in
Sava n na h. From time to tim e,
Dr. T ullius will do anesthesia
wo rk for RiclJa ,"d Grcco '83 at
his plast ic surgery ce nter.
Cha rles has two children ,
David , age two and one-half,
and Claire , age six months.
Prodromes Ve,-vereli of
Allen town , PA is ce lebra ting
th e birth of his son, Alexander
Rob ert , born Mar ch 21, 1996.
His dau ghter, Elizabeth , turned
th ree years old in june.
Madel inc S. Wood-Ciccllinelli
of West Chester , PA and her
hu sb and have one child,
Cari ssa Claire , who turns three
in Decem ber.
'90
Alicc R. Dicll of Los Angeles,
CA is now a s taff internist at
th e Medical Group of Beverl y
Hills , Inc., a division of th e
Ceda rs- inai I-1 ealt hcare
Foundation .
Marc ], Levinc of St.
Petersburg, Fl. has joined
Ta mpa Bay Orthopaedic
Spec ialis ts with offices in St.
Petersburg. T he group has
provided ad ult orthopaedi cs in
th at area for 25 yea rs. Dr. Levin
co mpleted his spine su rge ry
fellowship at Emo ry Univers ity
Hospital last j uly . He is now a
dad as well as happily married
to Robine, Benjamin athan
Levine celebrates his first
birthday in j anuary.
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3 7 J E F F ER S O N Me d ica l C oll e g e A l u m n i Bull et in
A Green Thumb's Paradise
bo ug ht six acres in cluding
some old ruins. In 1982 Dr.
Scu ll retir ed from his 30-year
practice of rh eumatology, and
staye d on Nevis yea r-round.
He has raised more than 110
species of tropical frui t. Of
his 500 or chids , ma ny have
been "natur alized" onto
surrounding trees . "Every
plant wants to grow," Dr.
Scu ll theorizes . "If it dies , it's
someth ing I'm do ing wrong ."
-Malcolm Clendenin
hile many of us ar e
facing snow, Edward
Scull '48 and his wife ,
Malelon, have escaped to
warm Nevis in the West
Indies . On this isle of
eme rald foliage , mountains,
monkeys, and wild do nkeys ,
Dr. Scull has cu ltivated
his inte rest in horticulture.
The Scu lls firs t visi ted from
Hartford, Co nnecticut
(w here he also gardened)
in 1962, and a year lat er
'T he MilL"
a Four-story
structure
dating from
about 1800,
houses
living and
sleeping
areas amid
the gard ens,
David N. FerraroJ r. of
Pittsburgh , PA just had an
addition to th e famil y. Maria
Elizabeth was born April 8 ,
1996 to David and Melanie.
Ga vill C. Barr of Springfield ,
NJ wa s named Chief
Resident in th e Emergen cy
Medi cine Program at New
York Univers ity Medi cal
Cen te r. He will complete
hi s training in june 199 7.
Ma ry Am I G. Hailes of
Havertown , PA and her
husband , Dave Trephan, ar e
th e proud parents of Brian
Alexande r, born Ju ly 17,1996.
Michael C. So'wl of Fort Lee ,
NJ co mpleted his residen cy
in Preventive Medi cin e at
th e University of Maryland
Medi cal System in June.
Michael now has an M.5. in
addition to an M.D . after hi s
nam e; he obtained a Master
of Science degree in
Epide m iology and Preventive
Medi cin e while doing his
residen cy. He is curren tly
working for Merck-Medco
Managed Care in Montvale ,
NJ as th e Asso ciate Dir ector
of Ou tco mes and
Performan ce Assessme n t.
'96
'93
Cen te r Family Practi ce
Residen cy Pro gram .
Co ng ra tu lations to
C. A lItllOlIY Wolfe Jr. of
Baltimore, MD who proudly
announces his marriage to
Lisa C. Bauman on September
7 in Gos he n, CT . Among
those in attendance at
th e ceremony wa s Eva ll
Weismall '92. Dr. Wolfe is
curren tly working as a
military ph ysician with th e
rank of Cap tain at Aberdeen
Provin g Ground, MD.
'91
'92 Fifth Reunion Ju ne 6-8
Stephen B. Kupferberg and
Marcia Liu o f Martinez, GA
are th e proud parents ofJ acob
Eric Kup ferberg, now one-
and-a- ha lf. They are at th e
Med ical Co llege of Geo rgia
where Stephe n is co mpleting
th e last year of his oto lary n-
gology resid en cy, and Marcia
is in th e second yea r of her
cardiology fellowsh ip .
Maria E. Pharr of Havertown ,
PA has received a J efferson
facu lty appo intme n t as an
Assistan t Professor of Fam ily
Med icine .
Helell K. Sava of Honolulu ,
HI is th e proud mother of
Vince nt Jam es Sava Ill , born
Februa ry 28, 1996 . Dr. Sava
is an attend ing ph ysician at
th e Tripier Army Medi cal
Kyrill D unston has joine d
Cha tham Ob-Gy n Associates
in Savan nah, GA. She received
th e Resid ent Achieve me n t
Awar d fro m th e Soc iety of
Lap aro -Endoscopi c Surgeo ns
while a resid ent at th e Medi cal
Cen ter of Delaware.
Andrea E. Gordoll of Fede ral
Way , WA completed a two-
year fellowshi p in Fam ily
Prac tice Fac u lty Development
in Pittsburgh , PA th rough a
project spo nso red by St.
Margaret Mem orial Hospital.
W hile co mpleting her
fellowsh ip , she'd done a
research proj ect in a co m ple-
mentary medi cin e mod alit y
called Therape u tic To uc h,
whic h is curren tly bein g
prepa red for submission to a
jo urna l. And rea has s ta rte d
her new faculty positi on in
the rural bran ch o f th e
Tacom a Family Pra cti ce
Residen cy Program in
Puyallup , WA.
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